( (TITLE (S (NP-SBJ (JJ Genetic) (NN background)) (VP (VBZ determines) (NP (NP (NN response)) (PP (IN to) (NP (NN hemostasis) (CC and) (NN thrombosis))))))) )
( (HEADING (NP (NN Abstract))) )
( (HEADING (NP (NN Background))) )
( (S (NP-SBJ (NN Thrombosis)) (VP (VBZ is) (NP-PRD (NP (DT the) (ADJP (JJ fatal) (CC and) (VBG disabling)) (NN consequence)) (PP (IN of) (NP (NP (JJ cardiovascular) (NNS diseases)) (, ,) (NP (NP (DT the) (VBG leading) (NN cause)) (PP (IN of) (NP (NN mortality) (CC and) (NN morbidity))) (PP-LOC (IN in) (NP (JJ Western) (NNS countries)))))))) (. .)) )
( (S (NP-SBJ (NP (CD Two) (JJ inbred) (NN mouse) (NNS strains)) (, ,) (NP (NP (NN C57BL) (HYPH /) (NN 6J)) (CC and) (NP (NN A) (HYPH /) (NN J)))) (, ,) (VP (VBP have) (NP (NP (JJ marked) (NNS differences)) (PP (IN in) (NP (NP (NN susceptibility)) (PP (IN to) (NP (NP (NN obesity)) (, ,) (NP (NN atherosclerosis)) (, ,) (CC and) (NP (NN vessel) (NN remodeling)))))))) (. .)) )
( (S (ADVP (RB However)) (, ,) (NP-SBJ (NP (PRP it)) (SBAR-1 (-NONE- *EXP*))) (VP (VBZ is) (ADJP-PRD (JJ unclear)) (SBAR-1 (WHADVP-2 (WRB how)) (S (NP-SBJ (DT these) (JJ diverse) (JJ genetic) (NNS backgrounds)) (VP (VBP influence) (NP (NP (NNS pathways)) (VP (VBN known) (S (NP-SBJ (-NONE- *)) (VP (TO to) (VP (VB regulate) (NP (NN thrombosis) (CC and) (NN hemostasis))))))) (ADVP-MNR-2 (-NONE- *T*)))))) (. .)) )
( (S (NP-SBJ (NP (DT The) (NN objective)) (PP (IN of) (NP (DT this) (NN study)))) (VP (VBD was) (S-PRD (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VP (VB evaluate) (NP (NN thrombosis) (CC and) (NN hemostasis)) (PP-LOC (IN in) (NP (DT these) (CD two) (JJ inbred) (NNS strains)))) (CC and) (VP (VB determine) (NP (NP (DT the) (JJ phenotypic) (NN response)) (PP (IN of) (NP (NML (NN A) (HYPH /) (NN J)) (NNS chromosomes)))) (PP-LOC (IN in) (NP (DT the) (NML (NN C57BL) (HYPH /) (NN 6J)) (NN background)))))))) (. .)) )
( (HEADING (NP (NNS Methods))) )
( (S (NP-SBJ-1 (NML (NML (NN A) (HYPH /) (NN J)) (CC and) (NML (NN C57Bl) (HYPH /) (NN 6J))) (NNS mice)) (VP (VBD were) (VP (VBN evaluated) (NP-1 (-NONE- *)) (PP-PRP (IN for) (NP (NP (NNS differences)) (PP (IN in) (NP (NN thrombosis) (CC and) (NN hemostasis))))))) (. .)) )
( (S (S (NP-SBJ-1=4 (DT A) (NN thrombus)) (VP (VBD was) (VP=3 (VBN induced) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (DT the) (JJ carotid) (NN artery))) (PP-MNR (IN by) (NP (NP (NN application)) (PP (IN of) (NP (DT the) (VBN exposed) (NN carotid))) (PP (IN to) (NP (JJ ferric) (NN chloride)))))))) (CC and) (S (NP-SBJ-2=4 (NN blood) (NN flow)) (VP=3 (VBN measured) (NP-2 (-NONE- *)) (SBAR-TMP (IN until) (S (NP-SBJ (DT the) (NN vessel)) (VP (VBD occluded)))))) (. .)) )
( (S (NP-SBJ-1 (NP (NML (NN Bleeding) (CC and) (NN rebleeding)) (NNS times)) (, ,) (PP (IN as) (NP (NP (JJ surrogate) (NNS markers)) (PP (IN for) (NP (NN thrombosis) (CC and) (NN hemostasis)))))) (, ,) (VP (VBD were) (VP (VBN determined) (NP-1 (-NONE- *)) (PP-TMP (IN after) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VP (VBG clipping) (NP (DT the) (NN tail))) (CC and) (VP (VBG placing) (PP-LOC (IN in) (NP (JJ warm) (NN saline))))))))) (. .)) )
( (S (NP-SBJ-1 (NP (QP (CD Twenty) (HYPH -) (CD one)) (NN chromosome) (NN substitution) (NNS strains)) (, ,) (NP (NP (NML (NN A) (HYPH /) (NN J)) (NNS chromosomes)) (PP-LOC (IN in) (NP (DT a) (NML (NN C57BL) (HYPH /) (NN 6J)) (NN background))))) (, ,) (VP (VBD were) (VP (VBN screened) (NP-1 (-NONE- *)) (PP-PRP (IN for) (NP (NP (NN response)) (PP (IN to) (NP (DT the) (NML (NN tail) (NN bleeding)) (NN assay))))))) (. .)) )
( (HEADING (NP (NNS Results))) )
( (S (NP-SBJ-1 (NML (NN Thrombus) (NN occlusion)) (NN time)) (VP (VBD was) (ADVP (RB markedly)) (VP (VBN decreased) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (DT the) (NML (NN A) (HYPH /) (NN J)) (NNS mice))) (PP (VBN compared) (PP (IN to) (NP (NML (NN C57BL) (HYPH /) (NN 6J)) (NNS mice)))))) (. .)) )
( (S (S (NP-SBJ (NML (NN Tail) (NN bleeding)) (NN time)) (VP (VBD was) (ADJP-PRD (JJ similar)) (PP-LOC (IN in) (NP (DT the) (CD two) (NNS strains))))) (, ,) (CC but) (S (NP-SBJ-1 (NN rebleeding) (NN time)) (VP (VBD was) (ADVP (RB markedly)) (VP (VBN increased) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (DT the) (NML (NN A) (HYPH /) (NN J)) (NNS mice))) (PP (VBN compared) (PP (IN to) (NP (NML (NN C57BL) (HYPH /) (NN 6J)) (NNS mice))))))) (. .)) )
( (S (S (NP-SBJ (NP (NN Coagulation) (NNS times)) (CC and) (NP (NN tail) (NN morphology))) (VP (VBD were) (ADJP-PRD (JJ similar)))) (, ,) (CC but) (S (NP-SBJ (NML (NN tail) (NN collagen)) (NN content)) (VP (VBD was) (ADJP-PRD (NP (JJR higher)) (PP-2 (-NONE- *ICH*))) (PP-LOC (IN in) (NP (NN A) (HYPH /) (NN J) (NML-1 (-NONE- *RNR*)))) (PP-2 (IN than) (NP (NN C57BL) (HYPH /) (NN 6J) (NML-1 (-NONE- *RNR*)))) (NML-1 (NNS mice)))) (. .)) )
( (S (NP-SBJ-1 (NP (CD Three) (NN chromosome) (NN substitution) (NNS strains)) (, ,) (NP (NP (NML (NN B6) (HYPH -) (NN Chr5A)) (HYPH /) (NN J)) (, ,) (NP (NML (NN B6) (HYPH -) (NN Chr11A)) (HYPH /) (NN J)) (, ,) (CC and) (NP (NML (NN B6) (HYPH -) (NN Chr17A)) (HYPH /) (NN J)))) (, ,) (VP (VBD were) (VP (VBN identified) (NP-1 (-NONE- *)) (PP (IN with) (NP (NP (VBN increased) (NN rebleeding) (NN time)) (, ,) (NP (NP (DT a) (NN phenotype)) (ADJP (JJ similar) (PP (IN to) (NP (NML (NN A) (HYPH /) (NN J)) (NNS mice))))))))) (. .)) )
( (S (S (NP-SBJ (NP (NNS Mice)) (ADJP (JJ heterosomic) (PP (IN for) (NP (NNS chromosomes) (NML (CD 5) (CC or) (CD 17)))))) (VP (VBD had) (NP (NP (NN rebleeding) (NNS times)) (ADJP (JJ similar) (PP (IN to) (NP (NML (NN C57BL) (HYPH /) (NN 6J)) (NNS mice))))))) (, ,) (CC but) (S (SBAR-TMP (WHADVP-1 (IN when)) (S (NP-SBJ-2 (NP (DT these) (CD two) (NN chromosome) (NN substitution) (NNS strains)) (, ,) (NP (NP (NML (NN B6) (HYPH -) (NN Chr5A)) (HYPH /) (NN J)) (CC and) (NP (NML (NN B6) (HYPH -) (NN Chr17A)) (HYPH /) (NN J)))) (, ,) (VP (VBD were) (VP (VBN crossed) (NP-2 (-NONE- *)) (ADVP-TMP-1 (-NONE- *T*)))))) (, ,) (NP-SBJ-3 (DT the) (NML (NN A) (HYPH /) (NN J)) (NN phenotype)) (VP (VBD was) (VP (VBN restored) (NP-3 (-NONE- *)) (PP-LOC (IN in) (NP (DT these) (ADJP (RB doubly) (JJ heterosomic)) (NN progeny)))))) (. .)) )
( (HEADING (NP (NN Conclusion))) )
( (S (NP-SBJ (DT These) (NNS results)) (VP (VBP indicate) (SBAR (IN that) (S (NP-SBJ (NP (NN susceptibility)) (PP (IN to) (NP (JJ arterial) (NML (NN thrombosis) (CC and) (NN haemostasis))))) (VP (VBZ is) (ADJP-PRD (RB remarkably) (JJ different)) (PP-LOC (IN in) (NP (NML (NML (NML (NN C57BL) (HYPH /)) (CC and) (NML (NN A) (HYPH /))) (NN J)) (NNS mice))))))) (. .)) )
( (S (S (NP-SBJ-2 (NP (CD Three) (NML (NN A) (HYPH /) (NN J)) (NN chromosome) (NN substitution) (NNS strains)) (SBAR-3 (-NONE- *ICH*))) (VP (VBD were) (VP (VBN identified) (NP-2 (-NONE- *)) (SBAR-3 (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBD expressed) (NP (NP (DT a) (NN phenotype)) (ADJP (JJ similar) (PP (IN to) (NP (NN A) (HYPH /) (NN J)))))))) (PP-PRP (IN for) (NP (VBG rebleeding)))))) (, ,) (S (NP-SBJ (DT the) (NML (NN C57Bl) (HYPH /) (NN 6J)) (NN background)) (VP (MD could) (VP (VB modify) (NP (DT the) (NML (NN A) (HYPH /) (NN J)) (NN phenotype))))) (, ,) (CC and) (S (NP-SBJ (NP (DT the) (NN combination)) (PP (IN of) (NP (CD two) (NML (NN A) (HYPH /) (NN J)) (NN QTL)))) (VP (MD could) (VP (VB restore) (NP (DT the) (NN phenotype))))) (. .)) )
( (S (NP-SBJ (DT The) (NML (NML (JJ diverse) (JJ genetic) (NNS backgrounds)) (CC and) (NML (NML (NNS differences)) (PP (IN in) (NP (NP (NN response)) (PP (IN to) (NP (NP (ADJP (NP (JJ vascular) (NN injury)) (VBN induced)) (NN thrombosis)) (CC and) (NP (DT the) (NML (NN tail) (NN bleeding)) (NN assay))))))))) (, ,) (VP (VBP suggest) (NP (NP (DT the) (NN potential)) (PP (IN for) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG identifying) (NP (NP (JJ novel) (JJ genetic) (NNS determinants)) (PP (IN of) (NP (JJ thrombotic) (NN risk))))))))) (. .)) )
( (HEADING (NP (NN Background))) )
( (S (NP-SBJ (NN Family) (NN history) (PRN (-LRB- [) (NP (CD 1)) (-RRB- ]))) (VP (VBZ is) (NP-PRD (NP (DT the) (JJS strongest) (NN risk) (NN factor)) (PP (IN for) (NP (NP (JJ cardiovascular) (NNS diseases)) (-LRB- -LRB-) (NP (NNS CVD)))))) (-RRB- -RRB-) (. .)) )
( (S (SBAR-ADV (IN While) (S (NP-SBJ-1 (NP (DT a) (NN number)) (PP (IN of) (NP (JJ genetic) (NNS mutations)))) (VP (VBP have) (VP (VBN been) (VP (VBN identified) (NP-1 (-NONE- *))))))) (, ,) (NP-SBJ (DT these)) (VP (VBP account) (PP (IN for) (NP (NP (RB only) (DT a) (JJ small) (NN percentage)) (PP (IN of) (NP (NP (DT the) (NNS CVD)) (PP-LOC (IN in) (NP (JJ human) (NNS populations)))))))) (. .)) )
( (S (NP-SBJ (NP (NN Thrombus) (NN formation)) (PP (IN on) (NP (VBN fissured) (JJ atherosclerotic) (NNS plaques)))) (VP (VP (VBZ is) (NP-PRD (NP (DT the) (VBG precipitating) (NN event)) (PP (IN in) (NP (NP (DT the) (NN transition)) (PP (IN from) (NP (DT a) (ADJP (JJ stable) (CC or) (JJ subclinical)) (JJ atherosclerotic) (NN disease))))))) (CC and) (VP (VBZ leads) (PP (IN to) (NP (NP (JJ acute) (JJ myocardial) (NN infarction)) (, ,) (NP (JJ ischemic) (NN stroke)) (CC or) (NP (ADJP (JJ peripheral) (JJ arterial)) (NN occlusion)))))) (. .)) )
( (S (NP-SBJ-1 (ADJP (JJ Arterial) (CC and) (JJ venous)) (NN thrombosis)) (VP (VP (VBP are) (NP-PRD (JJ complex) (NNS responses))) (CC and) (VP (VBP are) (VP (VBN influenced) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (JJ multiple) (ADJP (JJ genetic) (CC and) (JJ environmental)) (NNS factors))) (PRN (-LRB- [) (NP (NP (CD 2)) (PP (SYM -) (NP (CD 5)))) (-RRB- ]))))) (. .)) )
( (S (NP-SBJ-1 (NP (NNS Polymorphisms) (CC and) (NNS mutations)) (PP (IN in) (NP (NP (NN coagulation) (NNS factors)) (, ,) (NP (JJ fibrinolytic) (NNS factors)) (, ,) (NP (NML (NN platelet) (NN surface)) (NNS receptors)) (, ,) (NP (NN methylenetetrahydrofalate) (NN reductase)) (, ,) (NP (JJ endothelial) (NML (JJ nitric) (NN oxide)) (NN synthase)) (, ,) (CC and) (NP (JJ antioxidant) (NNS enzymes))))) (VP (VBP have) (VP (VBN been) (VP (VBN implicated) (NP-1 (-NONE- *)) (PP (IN as) (NP (NP (JJ genetic) (NNS determinants)) (PP (IN of) (NP (NP (NN susceptibility)) (PP (IN to) (NP (NN thrombosis))))))) (PRN (-LRB- [) (NP (CD 6) (, ,) (CD 7)) (-RRB- ]))))) (. .)) )
( (S (NP-SBJ-1 (JJ Great) (NNS strides)) (VP (VBP have) (VP (VBN been) (VP (VBN made) (NP-1 (-NONE- *)) (PP (IN in) (NP (NP (DT the) (NML (NN diagnosis) (CC and) (NN treatment))) (PP (IN of) (NP (NN thrombosis))))) (PP-TMP (IN in) (NP (DT the) (JJ last) (NN decade)))))) (. .)) )
( (S (ADVP (RB However)) (, ,) (NP-SBJ (NP (NNS strategies)) (SBAR (WHNP-2 (-NONE- *0*)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (TO to) (VP (VB prevent) (NP (NN thrombosis))))))) (VP (VBP have) (VP (VBN lagged) (ADVP (RB far) (RB behind)) (PP-PRP (IN due) (, ,) (PP (IN in) (ADJP (JJ part))) (, ,) (IN to) (NP (NP (DT the) (NN contribution)) (PP (IN of) (NP (NP (ADJP (ADJP (JJ multiple)) (, ,) (CC and) (ADJP (ADVP (RB as) (RB yet)) (JJ undefined))) (, ,) (JJ genetic) (NNS factors)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBP lead) (PP (IN to) (NP (JJ thrombotic) (NN risk)))))))))))) (. .)) )
( (S (ADVP (RB Moreover)) (, ,) (NP-SBJ-1 (NP (PRP it)) (SBAR-2 (-NONE- *EXP*))) (VP (VBZ remains) (S (NP-SBJ-1 (-NONE- *)) (ADJP-PRD (JJ unclear))) (SBAR-2 (WHADVP-3 (WRB how)) (S (NP-SBJ (JJ genetic) (NN background)) (VP (VP (VP (VBZ influences) (NP (NP (DT the) (NN function)) (PP (IN of) (NP (NP (NNS molecules) (CC and) (NNS pathways)) (VP (VBN known) (S (NP-SBJ (-NONE- *)) (VP (TO to) (VP (VB regulate) (NP (NN thrombus) (NML (NN formation) (CC and) (NN lysis))))))))))) (CC and) (, ,) (VP (ADVP (RB thereby)) (, ,) (VBZ contributes) (PP (IN to) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (JJ thrombotic) (NN disease))))))) (ADVP-MNR-3 (-NONE- *T*)))))) (. .)) )
( (S (NP-SBJ-1 (NP (JJ Many)) (PP (IN of) (NP (NP (DT the) (JJ available) (NML (JJ inbred) (NN mouse)) (NNS strains)) (, ,) (PP (JJ such) (IN as) (NP (NP (NP (NN C57BL) (HYPH /) (NN 6J)) (-LRB- -LRB-) (NP (NN B6))) (-RRB- -RRB-) (CC and) (NP (NN A) (HYPH /) (NN J))))))) (, ,) (VP (VBP have) (VP (VBN been) (VP (VBN classified) (NP-1 (-NONE- *)) (PP (IN as) (ADJP (JJ resistant) (CC or) (JJ susceptible) (PP (IN to) (NP (JJ particular) (JJ complex) (NNS diseases))))) (PRN (-LRB- -LRB-) (NP (NN Table) (CD 1)) (-RRB- -RRB-))))) (. .)) )
( (S (NP-SBJ (DT These) (CD two) (NNS strains)) (VP (VBP have) (NP (NP (JJ diverse) (NNS responses)) (PP (IN to) (NP (NP (ADJP (NN diet) (HYPH -) (VBN induced)) (NN obesity) (PRN (-LRB- [) (NP (CD 8)) (-RRB- ])) (PRN (-LRB- -LRB-) (FRAG (NP-SBJ (NN B6)) (ADJP-PRD (JJ susceptible))) (: ;) (FRAG (NP-SBJ (NN A) (HYPH /) (NN J)) (ADJP-PRD (JJ resistant))) (-RRB- -RRB-))) (, ,) (NP (ADJP (NN diet) (HYPH -) (VBN induced)) (NN atherosclerosis) (PRN (-LRB- -LRB-) (FRAG (NP-SBJ (NN B6)) (ADJP-PRD (JJ susceptible))) (: ;) (FRAG (NP-SBJ (NN A) (HYPH /) (NN J)) (ADJP-PRD (JJ resistant))) (-RRB- -RRB-)) (PRN (-LRB- [) (NP (CD 9)) (-RRB- ]))) (, ,) (NP (ADJP (NP (JJ arterial) (NN ligation)) (HYPH -) (VBN induced)) (JJ neointimal) (NN hyperplasia) (PRN (-LRB- -LRB-) (FRAG (NP-SBJ (NN B6)) (ADJP-PRD (JJ resistant))) (: ;) (FRAG (NP-SBJ (NN A) (HYPH /) (NN J)) (ADJP-PRD (JJ resistant))) (-RRB- -RRB-))) (, ,) (CC and) (NP (ADJP (NN ligation) (VBN induced)) (NN vessel) (NN remodeling) (PRN (-LRB- -LRB-) (FRAG (NP-SBJ (NN B6)) (ADJP-PRD (JJ resistant))) (: ;) (FRAG (NP-SBJ (NN A) (HYPH /) (NN J)) (ADJP-PRD (JJ susceptible))) (-RRB- -RRB-) (PRN (-LRB- [) (NP (CD 10)) (-RRB- ])))))))) (. .)) )
( (S (S (NP-SBJ (DT These) (NNS conditions)) (VP (VBP are) (ADJP-PRD (VBG predisposing) (PP (IN to) (NP (NN thrombosis)))) (ADVP-MNR (FW per) (FW se)))) (, ,) (CC but) (S (NP-SBJ-1 (DT these) (NNS mice)) (VP (VBP have) (RB not) (VP (VBN been) (ADVP-MNR (RB systematically)) (VP (VBN evaluated) (NP-1 (-NONE- *)) (PP (IN for) (NP (NN thrombosis))))))) (. .)) )
( (S (NP-SBJ (NP (NN Clot) (NML (NN formation) (CC and) (NN lysis))) (, ,) (SBAR (WHNP-1 (WDT which)) (S (NP-SBJ-1 (-NONE- *T*)) (ADVP (RB ultimately)) (VP (VBP determine) (NP (NN thrombosis)))))) (, ,) (VP (VBZ requires) (NP (NP (NN platelet) (NN aggregation)) (, ,) (NP (NN coagulation)) (, ,) (CC and) (NP (JJ fibrinolytic) (NNS functions)))) (. .)) )
( (S (S (NP-SBJ (NP (NNS Interactions)) (PP (IN among) (NP (DT these) (NNS pathways)))) (VP (MD may) (VP (VB occur)))) (CC and) (S (NP-SBJ (JJ additional) (NNS factors)) (VP (MD may) (VP (VB modulate) (NP (DT these) (NNS processes))))) (. .)) )
( (S (NP-SBJ-1 (NP (NN Identification)) (PP (IN of) (NP (NP (JJ novel) (NML (NNS modulators) (CC and) (NNS factors))) (PP (IN of) (NP (DT these) (NNS pathways)))))) (VP (MD can) (VP (VB be) (VP (VBN identified) (NP-1 (-NONE- *)) (PP-MNR (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG associating) (NP (DT the) (NN phenotype)) (PP (IN with) (NP (NP (NP (DT a) (NN location) (-LRB- -LRB-) (AFX s) (-RRB- -RRB-)) (PP-LOC (IN on) (NP (DT a) (JJ specific) (NN chromosome)))) (, ,) (NP (DT a) (NML (NML (JJ quantitative) (NN trait) (NN locus)) (-LRB- -LRB-) (NML (NN QTL)))))))))))) (-RRB- -RRB-) (. .)) )
( (HEADING (NP (NN Table) (CD 1))) )
( (HEADING (NP (NP (NN Identification)) (PP (IN of) (NP (NP (NNS mice)) (ADJP (JJ susceptible) (CC or) (JJ resistant) (PP (IN to) (NP (NP (NN obesity)) (, ,) (NP (NN atherosclerosis)) (, ,) (CC and) (NP (JJ vascular) (NN injury))))))))) )
( (CAPTION (NP (NP (NP (NN R)) (: :) (ADJP-TTL (JJ resistant))) (: ;) (NP (NP (NN S)) (: :) (ADJP-TTL (JJ susceptible))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NN Reference)) (VP (VBN provided) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NP (NN number)) (PP (IN in) (NP (NN parenthesis)))))) (. .))) )
( (CAPTION (S (NP-SBJ (NML (NML (NN Lepob)) (, ,) (NML (NN Plg) (SYM -) (HYPH /) (SYM -)) (, ,) (CC and) (NML (NML (NN PAI) (HYPH -) (NN F1)) (SYM -) (HYPH /) (SYM -))) (NNS mice)) (VP (VBD were) (PP-PRD (IN in) (NP (DT a) (NN B6) (NN background)))) (. .))) )
( (S (NP-SBJ-1 (NP (DT A) (NN panel)) (PP (IN of) (NP (NP (NN chromosome) (NN substitution) (NNS strains)) (-LRB- -LRB-) (NP (NNS CSS))))) (-RRB- -RRB-) (VP (VBD was) (VP (VBN generated) (NP-1 (-NONE- *)) (PRN (-LRB- [) (NP (CD 11)) (-RRB- ])) (PP (IN by) (NP-LGS (NP (DT a) (`` ``) (ADJP (NN marker) (HYPH -) (VBN assisted)) ('' '') (NN breeding) (NN program)) (SBAR (WHADVP-3 (WRB where)) (S (NP-SBJ-2 (NP (DT the) (NN progeny)) (PP (IN of) (NP (DT a) (NML (NML (NN B6)) (SYM ×) (NML (NN A) (HYPH /) (NN J))) (NN cross)))) (VP (VBD were) (ADVP (RB successively)) (VP (VBN backcrossed) (NP-2 (-NONE- *)) (PP (IN to) (NP (DT the) (NN B6) (NNS mice))) (ADVP-LOC-3 (-NONE- *T*)))))))))) (. .)) )
( (S (NP-SBJ-1 (JJ Genetic) (NNS markers)) (VP (VBD were) (VP (VBN used) (NP-1 (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB identify) (NP (NP (NN homozygosity)) (PP-LOC (IN in) (NP (NP (DT the) (NN background) (NML (-LRB- -LRB-) (NN B6) (-RRB- -RRB-)) (NML-2 (-NONE- *RNR*))) (CC and) (NP (DT the) (JJ individual) (NML (NN A) (HYPH /) (NN J)) (NML-2 (-NONE- *RNR*))) (NML-2 (NN chromosome)))))))))) (. .)) )
( (S (NP-SBJ (DT These) (NNS strains)) (VP (VBP have) (NP (NP (CD one) (NN chromosome)) (PP (IN from) (NP (NML (NN A) (HYPH /) (NN J)) (NNS mice)))) (PP-LOC (IN in) (NP (DT a) (NN B6) (NN background)))) (. .)) )
( (S (NP-SBJ (DT This)) (VP (VP (VBZ allows) (NP (NP (DT the) (NN identification)) (PP (IN of) (NP (NP (DT a) (NN trait)) (PP (IN in) (NP (QP (CD one) (CC or) (JJR more)) (NN CSS))))))) (CC and) (VP (VBZ implies) (SBAR (IN that) (S (NP-SBJ (QP (RB at) (RBS least) (CD one)) (NN QTL)) (VP (VBZ resides) (PP-LOC (IN on) (NP (DT this) (NN chromosome)))))))) (. .)) )
( (S (NP-SBJ (NP (NN Use)) (PP (IN of) (NP (DT this) (NN panel)))) (VP (VBZ requires) (NP (NP (JJR fewer) (NNS mice)) (SBAR-1 (-NONE- *ICH*))) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB determine) (NP (DT the) (NN QTL))))) (SBAR-1 (IN than) (SINV (VBZ does) (NP-SBJ (DT a) (ADJP (NN genome) (HYPH -) (JJ wide)) (NN scan)) (VP (-NONE- *?*))))) (. .)) )
( (S (NP-SBJ (DT Another) (NN advantage)) (VP (VBZ is) (NP-PRD (NP (DT the) (NN ability)) (PP (IN for) (NP (NP (NN detection)) (PP (IN of) (NP (NNS QTL))) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (JJ other) (NN QTL))))))))) (. .)) )
( (S (PP (IN In) (NP (NN addition))) (, ,) (NP-SBJ (NP (JJ initial) (NNS screens)) (PP (IN with) (NP (DT the) (NN CSS)))) (VP (VBP simplify) (NP (NP (DT the) (RB fine) (HYPH -) (VBG mapping)) (PP (IN of) (NP (NN QTL))))) (. .)) )
( (S (NP-SBJ-1 (NP (JJ Several) (NNS studies)) (PP (IN of) (NP (NP (DT this) (NN CSS) (NN panel)) (, ,) (NP (NP (NN B6) (NN Chr1) (HYPH -) (NN 19)) (, ,) (NP (NN X)) (, ,) (NP (NN YA) (HYPH /) (NN J)))))) (, ,) (VP (VP (VBP have) (VP (VBN been) (VP (VBN reported) (NP-1 (-NONE- *)) (PP (IN for) (NP (NP (NN behavior) (PRN (-LRB- [) (NP (CD 12)) (-RRB- ]))) (, ,) (NP (NN weight) (NN gain) (PRN (-LRB- [) (NP (CD 13)) (-RRB- ]))) (, ,) (NP (NNS sterols) (PRN (-LRB- [) (NP (CD 13)) (-RRB- ]))) (, ,) (CC and) (NP (NN plasma) (NML (NN amino) (NNS acids)) (NNS levels) (PRN (-LRB- [) (NP (CD 13) (, ,) (CD 14)) (-RRB- ])))))))) (, ,) (CC and) (VP (VBP have) (VP (VBN identified) (NP (NP (ADJP (JJ many) (JJR more)) (NN QTL)) (PP (IN than) (NP (NP (NP (NNS studies)) (PP (IN of) (NP (DT the) (JJ same) (NNS traits)))) (VP (VBG using) (NP (DT a) (ADJP (NN genome) (HYPH -) (JJ wide)) (NN scan))))))))) (. .)) )
( (S (NP-SBJ (NP (DT The) (NN purpose)) (PP (IN of) (NP (DT this) (NN study)))) (VP (VBD was) (S-PRD (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB evaluate) (NP (NP (DT the) (CD two) (JJ inbred) (NNS strains)) (PP (IN of) (NP (NNS mice)))) (PP-PRP (IN for) (NP (JJ prothrombotic) (NN risk))) (, ,) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG utilizing) (NP (NP (DT a) (NML (JJ ferric) (NN chloride)) (NML (JJ vascular) (NN injury)) (NN model)) (, ,) (NP (NML (NN tail) (NN bleeding)) (NN assay)) (, ,) (CC and) (NP (NP (NNS measures)) (PP (IN of) (NP (NN coagulation) (CC and) (NN fibrinolysis))))))))))) (. .)) )
( (S (NP-SBJ (NP (DT The) (NNS results)) (PP (IN of) (NP (DT this) (NN study)))) (VP (VBP indicate) (SBAR (IN that) (S (NP-SBJ (NP (DT the) (CD two) (JJ inbred) (NNS strains)) (, ,) (NP (NML (NML (NN B6)) (CC and) (NML (NN A) (HYPH /) (NN J))) (NNS mice))) (, ,) (VP (VBP have) (NP (NP (JJ diverse) (JJ prothrombotic) (NNS phenotypes)) (, ,) (ADJP (JJ unrelated) (PP (IN to) (NP (NP (NN coagulation)) (CC or) (NP (NN platelet) (NN aggregation)))))))))) (. .)) )
( (S (PP (IN In) (NP (NN addition))) (, ,) (PP-LOC (IN in) (NP (DT the) (NN CSS))) (, ,) (NP-SBJ-1 (NP (NN expression)) (PP (IN of) (NP (NP (DT the) (NML (NN A) (HYPH /) (NN J)) (NNS phenotypes)) (, ,) (NP (NN rebleeding) (NN time)) (CC and) (NP (JJ arterial) (NN occlusion))))) (, ,) (VP (VP (VBD was) (VP (VBN modified) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (DT the) (NN B6) (NN background))))) (, ,) (CC and) (VP (VBD suggested) (SBAR (IN that) (S (NP-SBJ (NNS interactions)) (VP (VBD occurred) (PP-LOC (IN among) (NP (DT the) (NML (NN A) (HYPH /) (NN J)) (NN QTL)))))))) (. .)) )
( (S (ADVP (RB Thus)) (, ,) (NP-SBJ (NP (PRP it)) (S-1 (-NONE- *EXP*))) (VP (MD should) (VP (VB be) (ADJP-PRD (JJ possible)) (S-1 (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB identify) (NP (NP (JJ independent) (JJ genetic) (NNS determinants)) (PP (IN of) (NP (NP (NN susceptibility)) (PP (IN to) (NP (NP (JJ pathological) (NN haemostasis)) (CC and) (NP (NN thrombosis)))))))))))) (. .)) )
( (HEADING (NP (NNS Methods))) )
( (HEADING (NP (NNS Mice))) )
( (S (NP-SBJ-1 (NP (DT The) (JJ inbred) (NNS strains)) (, ,) (NP (NN B6) (PRN (-LRB- -LRB-) (NP (NN #) (CD 000664)) (-RRB- -RRB-))) (, ,) (NP (NN Lepob) (PRN (-LRB- -LRB-) (NP (NN #) (CD 000632)) (-RRB- -RRB-))) (, ,) (NP (NN A) (HYPH /) (NN J) (PRN (-LRB- -LRB-) (NP (NN #) (CD 000646)) (-RRB- -RRB-))) (CC and) (NP (NP (ADJP (NN gene) (HYPH -) (VBN targeted)) (NML (NML (ADJP (NP (NML (NML (NN plasminogen)) (-LRB- -LRB-) (NML (NN Plg))) (-RRB- -RRB-) (NN activator) (NN inhibitor)) (JJ deficient)) (NNS mice)) (-LRB- -LRB-) (NML (NML (NML (NN PAI) (HYPH -) (CD 1)) (SYM -) (HYPH /) (SYM -) (-RRB- -RRB-) (PRN (-LRB- -LRB-) (NP (NN #) (CD 002507)) (-RRB- -RRB-)) (PRN (-LRB- [) (NP (CD 15)) (-RRB- ]))) (NNS mice)))) (PP-LOC (IN in) (NP (DT a) (NN B6) (NN background))))) (VP (VBD were) (VP (VBN obtained) (NP-1 (-NONE- *)) (PP (IN from) (NP (NP (NNP Jackson) (NNP Laboratory)) (-LRB- -LRB-) (NP-LOC (NNP Bar) (NNP Harbor)) (, ,) (NP-LOC (NNP Maine)))) (-RRB- -RRB-) (PP-TMP (IN at) (NP (NP (CD 6) (NNS wks)) (HYPH -) (PP (IN of) (HYPH -) (NP (NN age))))))) (. .)) )
( (S (NP-SBJ-1 (DT The) (NML (NN Plg) (SYM -) (HYPH /) (SYM -)) (NNS mice)) (VP (VBD were) (VP (VP (VBN generated) (NP-1 (-NONE- *)) (SBAR-ADV (IN as) (S (NP-SBJ-2 (-NONE- *PRO*)) (ADVP-TMP (RB previously)) (VP (VBN described) (NP-2 (-NONE- *)) (PRN (-LRB- [) (NP (CD 16)) (-RRB- ])))))) (CC and) (VP (VBN maintained) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (DT the) (NN B6) (NN background)))) (, ,) (VP (VBN generated) (NP-1 (-NONE- *)) (PP-MNR (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG crossing) (NP (NP (NNS mice)) (PP (IN from) (NP (DT the) (JJ original) (JJ mixed) (-LRB- -LRB-) (NML (NN B6) (HYPH :) (CD 129)) (-RRB- -RRB-) (NN background)))) (PP-TMP (IN for) (NP (CD eight) (NNS generations))) (PP (IN with) (NP (NN B6) (NNS mice))))))))) (. .)) )
( (S (S (NP-SBJ (DT The) (NML (NN Plg) (SYM -) (HYPH /) (SYM -)) (NNS mice)) (VP (VBP do) (RB not) (VP (VB reproduce) (ADVP-MNR (RB well))))) (CC and) (S (NP-SBJ-1 (NN Plg) (JJ heterozygous) (NNS pairs)) (VP (VBD were) (VP (VBN used) (NP-1 (-NONE- *)) (PP-PRP (IN for) (NP (NN breeding)))))) (. .)) )
( (S (NP-SBJ-1 (NP (NP (NNS Genotypes)) (-LRB- -LRB-) (NP (NP (NN Plg) (SYM +) (HYPH /) (SYM +)) (, ,) (NP (NN Plg) (SYM +) (HYPH /) (SYM -)) (, ,) (NP (NN Plg) (SYM -) (HYPH /) (SYM -)))) (-RRB- -RRB-) (PP (IN of) (NP (DT the) (NN offspring)))) (VP (VBD were) (VP (VBN determined) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NP (DT a) (NN PCR) (NN assay)) (PP-TMP (IN at) (NP (NP (QP (CD 3) (SYM –) (CD 4)) (NNS weeks)) (HYPH -) (PP (IN of) (HYPH -) (NP (NN age))))) (PP (IN from) (NP (DT an) (NN ear) (NN punch))))) (PRN (-LRB- [) (NP (CD 17)) (-RRB- ])))) (. .)) )
( (S (NP-SBJ-1 (NP (NN Breeding) (NNS pairs)) (PP (IN of) (NP (DT the) (NN CSS) (NNS mice)))) (VP (VBD were) (VP (VBN transferred) (NP-1 (-NONE- *)) (PP (IN from) (NP (NP (NNP Dr.) (NNP Nadeau) (POS 's)) (NN laboratory))))) (. .)) )
( (S (NP-SBJ-1 (DT All) (NNS mice)) (VP (VBD were) (VP (VBN housed) (CC and) (VBN bred) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NP (DT the) (NNP Biological) (NNP Resource) (NNP Unit)) (PP-LOC (IN at) (NP (NP (DT the) (NNP Cleveland) (NNP Clinic) (NNP Foundation)) (-LRB- -LRB-) (NP (NN CCF)))))))) (-RRB- -RRB-) (. .)) )
( (S (NP-SBJ-1 (NNS Mice)) (VP (VP (VBD were) (VP (VP (VBN housed) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (VBN sterilized) (NN isolator) (NNS cages)))) (, ,) (VP (VBN maintained) (NP-1 (-NONE- *)) (PP (IN on) (NP (DT a) (NML (NML (NML (CD 14) (NN hr)) (NN light)) (HYPH /) (NML (NML (CD 10) (NN hr)) (NN dark))) (NN cycle)))))) (, ,) (CC and) (VP (VBD were) (VP (VBN provided) (NP-1 (-NONE- *)) (NP (VBN sterilized) (NML (NN food) (CC and) (NN water))) (ADVP-MNR (FW ad) (FW libitum))))) (. .)) )
( (S (NP-SBJ-1 (NNS Mice)) (VP (VBD were) (VP (VP (VBN fed) (NP-1 (-NONE- *)) (NP (NP (DT a) (JJ standard) (JJ autoclavable) (NN laboratory) (NN diet)) (VP (VBG consisting) (PP (IN of) (: :) (NP (NP (NML (CD 23) (NN %)) (NN protein)) (, ,) (NP (NML (CD 4.5) (NN %)) (NN fat)) (, ,) (NP (NML (CD 6) (NN %)) (NN fiber)) (, ,) (PRN (-LRB- -LRB-) (NP (NP (NNP Purina)) (, ,) (NP-LOC (NNP St.) (NNP Louis)) (, ,) (NP-LOC (NNP MO))) (-RRB- -RRB-))))))) (, ,) (CC and) (VP (VBN tested) (NP-1 (-NONE- *)) (PP-TMP (IN between) (NP (NP (NML (CD 7) (CC and) (CD 9)) (NNS wks)) (HYPH -) (PP (IN of) (HYPH -) (NP (NN age)))))))) (. .)) )
( (S (NP-SBJ-1 (DT All) (NN animal) (NNS experiments)) (VP (VBD were) (VP (VBN performed) (NP-1 (-NONE- *)) (PP (IN in) (NP (NP (NN accordance)) (PP (IN with) (NP (NP (DT a) (NN protocol)) (VP (VBN approved) (NP (-NONE- *)) (PP (IN by) (NP-LGS (NP (DT the) (NNP Institutional) (NML (NML (NNP Animal) (NNP Care)) (CC and) (NML (NNP Research) (NNP Advisory))) (NNP Committee)) (PP-LOC (IN at) (NP (NNP CCF)))))))))))) (. .)) )
( (HEADING (NP (JJ Vascular) (NN injury))) )
( (S (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO To) (VP (VB induce) (NP (NN thrombosis) (NN formation)) (PP-LOC (IN in) (NP (DT the) (NN carotid) (NN artery)))))) (, ,) (NP-SBJ-1 (NP (DT a) (NML (NML (JJ ferric) (NN chloride)) (-LRB- -LRB-) (NML (NN FeCl3))) (-RRB- -RRB-) (NN model)) (PP (IN of) (NP (NN vessel) (NN injury))) (PRN (-LRB- [) (NP (CD 18) (, ,) (CD 19)) (-RRB- ]))) (VP (VBD was) (VP (VBN employed) (NP-1 (-NONE- *)))) (. .)) )
( (S (S (NP-SBJ-1 (NNS Mice)) (VP (VBD were) (VP (VBN anesthetized) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (NN ketamine) (HYPH /) (NN xylazine) (PRN (-LRB- -LRB-) (NP (NP (CD 80) (NNS mg)) (PP (SYM /) (NP (NN kg)))) (, ,) (NP (NP (CD 5) (NNS mg)) (PP (SYM /) (NP (NN kg)))) (-RRB- -RRB-))))))) (, ,) (S (NP-SBJ-2=4 (DT a) (NN midline) (JJ cervical) (NN incision)) (VP (VBD was) (VP=5 (VBN made) (NP-2 (-NONE- *))))) (CC and) (S (NP-SBJ-3=4 (DT the) (JJ left) (JJ common) (JJ carotid) (NN artery)) (VP=5 (VBN isolated) (NP-3 (-NONE- *)) (PP-MNR (IN by) (NP (JJ blunt) (NN dissection))))) (. .)) )
( (S (S (NP-SBJ-1 (DT The) (NN flow) (NN probe) (PRN (-LRB- -LRB-) (NP (NNP Transonic) (NNP Systems)) (, ,) (NP (NN model) (NN 0.5PSB)) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN placed) (NP-1 (-NONE- *)) (PP-LOC (IN under) (NP (DT the) (NN artery)))))) (CC and) (S (SBAR-TMP (WHADVP-2 (WRB when)) (S (NP-SBJ-3 (DT a) (JJ stable) (NN baseline)) (VP (VBD was) (VP (VBN reached) (NP-3 (-NONE- *)) (ADVP-TMP-2 (-NONE- *T*)))))) (, ,) (NP-SBJ-4 (NP (NP (DT a) (NML (NML (CD 0.5) (SYM ×) (CD 2)) (NN mm)) (NN strip)) (PP (IN of) (NP (NN filter) (NN paper)))) (VP (VBN saturated) (NP (-NONE- *)) (PP-MNR (IN with) (NP (NML (NML (CD 10) (NN %)) (NN FeCl3)) (NN solution))))) (VP (VBD was) (VP (VBN applied) (NP-4 (-NONE- *)) (PP (IN to) (NP (NP (DT the) (NN surface)) (PP (IN of) (NP (DT the) (JJ carotid) (NN artery))))) (PP-TMP (IN for) (NP (CD 3) (NNS min)))))) (. .)) )
( (S (NP-SBJ-1 (NN Occlusion) (NN time)) (VP (VBD was) (VP (VBN determined) (NP-1 (-NONE- *)) (PP-TMP (PP (IN from) (NP (NP (DT the) (NN addition)) (PP (IN of) (NP (DT the) (NN FeCl3) (NN solution))))) (PP (IN to) (NP (NP (NP (DT the) (NN occlusion)) (PP (IN of) (NP (DT the) (NN artery)))) (-LRB- -LRB-) (NP (NN minimum) (NN blood) (NN flow))))))) (-RRB- -RRB-) (. .)) )
( (S (NP-SBJ-2 (DT The) (NN flow) (NN probe)) (VP (VP (VBD was) (PP-PRD (IN in) (NP (NN place))) (PP-TMP (PP (IN from) (NP (NP (DT the) (NN establishment)) (PP (IN of) (NP (DT the) (NN baseline))))) (PP-TMP (IN until) (SBAR (NP-ADV (JJ several) (NNS min)) (IN after) (S (NP-SBJ-1 (DT the) (JJ stable) (NN occlusion)) (VP (VBD had) (VP (VBN been) (VP (VBN reached) (NP-1 (-NONE- *)))))))))) (CC or) (VP (VBD stopped) (PP-TMP (IN at) (NP (CD 30) (NNS min))) (SBAR-ADV (IN if) (S (NP-SBJ (PRP it)) (VP (VBD had) (RB not) (VP (VBN occluded))))))) (. .)) )
( (S (NP-SBJ-1 (NN Blood) (NN flow)) (VP (VBD was) (VP (VBN recorded) (NP-1 (-NONE- *)) (NP-TMP (DT every) (CD 10) (NN sec)) (PRN (-LRB- -LRB-) (NP (NNP Transonic) (NNP Systems)) (, ,) (NP (NN model) (NN TS420)) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ (EX There)) (VP (VBD was) (NP-PRD (NP (DT no) (NN difference)) (PP (IN in) (NP (NN body) (NN weight)))) (PP-LOC (IN among) (NP (NP (DT the) (NNS mice)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBD were) (VP (VBN tested) (NP-1 (-NONE- *)) (PP (IN in) (NP (DT the) (NML (JJ vascular) (NN injury)) (NN model)))))))))) (. .)) )
( (HEADING (NP (NML (NN Bleeding) (CC and) (NN rebleeding)) (NN assay))) )
( (S (S (PP-PRP (IN For) (NP (DT the) (NML (NN tail) (NN bleeding)) (NN assay))) (, ,) (NP-SBJ-1=4 (NNS mice)) (VP (VBD were) (VP=3 (VBN anesthetized) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (NN ketamine) (HYPH /) (NN xylazine) (PRN (-LRB- -LRB-) (NP (NP (CD 80) (NNS mg)) (PP (SYM /) (NP (NN kg)))) (, ,) (NP (NP (CD 5) (NNS mg)) (PP (SYM /) (NP (NN kg)))) (-RRB- -RRB-))))))) (, ,) (S (NP-SBJ-2=4 (DT the) (NN tail)) (VP=3 (VBN prewarmed) (NP-2 (-NONE- *)) (PP-TMP (IN for) (NP (CD 5) (NNS min))) (PP-LOC (IN in) (NP (NP (CD 10) (NNS mL)) (PP (IN of) (NP (NP (NN saline)) (PP (IN at) (NP (CD 37) (NNS °C))))))) (PP-LOC (IN in) (NP (DT a) (NN water) (NN bath))))) (. .)) )
( (S (S (NP-SBJ-1=2 (DT The) (NN tail)) (VP (VBD was) (VP=3 (VBN lifted) (NP-1 (-NONE- *)) (PP (IN from) (NP (DT the) (NN saline)))))) (CC and) (S (NP-SBJ-4=2 (DT a) (NML (CD 5) (NN mm)) (NN tail) (NN segment)) (VP=3 (VP (VBN amputated) (NP-4 (-NONE- *))) (CC and) (VP (ADVP-TMP (RB immediately)) (VBD returned) (NP-4 (-NONE- *)) (PP-LOC (IN to) (NP (DT the) (NN saline)))))) (. .)) )
( (S (NP-SBJ-1 (NN Bleeding) (NN time)) (VP (VBD was) (VP (VBN measured) (NP-1 (-NONE- *)) (PP (IN as) (NP (NP (DT the) (NN time)) (PP-TMP (PP (IN between) (NP (NP (DT the) (NN start)) (PP (IN of) (NP (VBG bleeding))))) (PP (IN to) (NP (NP (NN cessation)) (PP (IN of) (NP (NN bleeding)))))))))) (. .)) )
( (S (PP-MNR (IN With) (S-NOM (NP-SBJ (DT the) (NN tail)) (VP (VBG remaining) (PP-LOC (IN in) (NP (DT the) (JJ same) (NN saline) (NN solution)))))) (, ,) (NP-SBJ-1 (DT the) (NN rebleeding) (NN time)) (VP (VBD was) (VP (VBN measured) (NP-1 (-NONE- *)) (PP (IN from) (NP (NP (DT the) (NN time)) (PP-TMP (IN between) (NP (NP (NN bleeding) (NN cessation)) (CC and) (NP (NP (DT the) (NN start)) (PP (IN of) (NP (DT the) (JJ second) (NN bleeding)))))))))) (. .)) )
( (HEADING (NP (UCP (NML (NN Coagulation)) (, ,) (NML (NN Plg)) (, ,) (NML (NN α2) (HYPH -) (NN antiplasmin)) (, ,) (NML (NN fibrinogen)) (, ,) (ADJP (JJ fibrinolytic)) (CC and) (NML (NN PAI) (HYPH -) (CD 1))) (NNS assays))) )
( (S (S (NP-SBJ-1=3 (NNS Mice)) (VP (VBD were) (VP=4 (VP (VBN anesthetized) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (NN Isoflurane) (PRN (-LRB- -LRB-) (NP (NNP Abbott)) (-RRB- -RRB-))))) (, ,) (VP (VBN bled) (NP-1 (-NONE- *)) (PP (IN from) (NP (DT the) (JJ orbital) (NN sinus))) (PP (IN into) (NP (JJ uncoated) (JJ capillary) (NNS tubes))))))) (, ,) (CC and) (S (NP-SBJ-2=3 (NP (DT a) (NN drop)) (PP (IN of) (NP (NN blood)))) (ADVP-TMP (RB immediately)) (VP=4 (VP (VBN placed) (NP-2 (-NONE- *)) (PP-LOC (IN on) (NP (DT a) (NN reagent) (NN strip) (PRN (-LRB- -LRB-) (NP (NNP Synbiotics)) (-RRB- -RRB-)))) (PP-PRP (IN for) (NP (NML (NML (NML (NN prothrombin) (NN time)) (-LRB- -LRB-) (NML (NN PT))) (-RRB- -RRB-) (CC or) (NML (NML (VBN activated) (JJ partial) (NN thromboplastin) (NN time)) (-LRB- -LRB-) (NML (NN aPTT)))) (-RRB- -RRB-) (NNS determinations)))) (CC and) (VP (VBN inserted) (NP-2 (-NONE- *)) (PP-DIR (IN into) (NP (DT the) (VBN precalibrated) (NNP Coagulation) (NNP Analyzer) (PRN (-LRB- -LRB-) (NP (NNP SCA2000)) (, ,) (NP (NNP Synbiotics)) (-RRB- -RRB-))))))) (. .)) )
( (S (NP-SBJ-1 (NML (NN PAI) (HYPH -) (CD 1)) (NN activity)) (VP (VBD was) (VP (VBN determined) (NP-1 (-NONE- *)) (PP-MNR (VBG according) (PP (IN to) (NP (NP (DT the) (NN method)) (PP (IN of) (NP (NP (NNP Chandler)) (ADVP-ETC (FW et) (FW al)) (PRN (-LRB- [) (NP (CD 20)) (-RRB- ]))))))))) (. .)) )
( (S (NP-SBJ-1 (NML (NN PAI) (HYPH -) (CD 1)) (NN antigen) (NN concentration)) (VP (VBD was) (VP (VBN determined) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NNP ELISA) (PRN (-LRB- [) (NP (CD 21)) (-RRB- ])))) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VP (VBG using) (NP=3 (NN sheep) (HYPH -) (ADJP (AFX anti) (NN mouse)) (NN PAI) (HYPH -) (CD 1) (PRN (-LRB- -LRB-) (NP (NNP American) (NNP Diagnostica)) (-RRB- -RRB-))) (PP=2 (IN as) (NP (DT the) (NN capture) (NN antibody)))) (CC and) (VP (NP=3 (NN mouse) (NN PAI) (HYPH -) (CD 1) (PRN (-LRB- -LRB-) (NP (NNP American) (NNP Diagnostica)) (-RRB- -RRB-))) (PP=2 (IN as) (NP (DT the) (JJ standard) (PRN (-LRB- -LRB-) (NP (NP (QP (CD 0) (SYM –) (CD 3.5)) (NNS ng)) (PP (SYM /) (NP (NN mL)))) (-RRB- -RRB-))))))))) (. .)) )
( (S (S (NP-SBJ-1=2 (NN Plg)) (VP (VBD was) (VP=3 (VBN determined) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (DT a) (JJ chromogenic) (NN assay))) (PRN (-LRB- [) (NP (CD 22)) (-RRB- ]))))) (CC and) (S (NP-SBJ-4=2 (DT the) (JJ fibrinolytic) (NN activity)) (VP=3 (VBN determined) (NP-4 (-NONE- *)) (PP-MNR (IN by) (NP (NN fibrin) (NN degradation))) (PRN (-LRB- [) (NP (CD 23)) (-RRB- ])))) (. .)) )
( (S (PP-PRP (IN For) (NP (NP (DT the) (JJ negative) (NNS controls)) (PP (IN in) (NP (DT these) (NNS assays))))) (, ,) (NP-SBJ-1 (NP (NN plasma)) (PP (IN from) (NP (ADJP (NP (NP (NN PAI) (HYPH -) (CD 1)) (CC or) (NP (NN Plg))) (JJ deficient)) (NNS mice)))) (VP (VBD was) (VP (VBN used) (NP-1 (-NONE- *)))) (. .)) )
( (S (S (NP-SBJ-1=2 (ADJP (RB Functionally) (JJ active)) (NN mouse) (NN α2) (HYPH -) (NN antiplasmin)) (VP (VBD was) (VP (VBN determined) (NP-1 (-NONE- *)) (PP-MNR=3 (IN with) (NP (NP (DT a) (NML (NN plasmin) (NN capture)) (NN assay)) (CC and) (NP (NP (NN detection)) (PP (IN with) (NP (DT a) (NN mouse) (NN antibody) (PRN (-LRB- -LRB-) (NP (NP (NNP Molecular) (NNPS Innovations)) (, ,) (NP-LOC (NNP Southfield)) (, ,) (NP-LOC (NNP MI))) (-RRB- -RRB-)))))))))) (, ,) (CC and) (S (NP-SBJ=2 (NN fibrinogen)) (PP-MNR=3 (IN with) (NP (NP (DT an) (NN ELISA) (NN assay)) (PP (IN with) (NP (NP (NNS antibodies)) (SBAR (WHNP-4 (WDT that)) (S (NP-SBJ-4 (-NONE- *T*)) (VP (VBP recognize) (NP (NN mouse) (NN fibrinogen))))) (PRN (-LRB- -LRB-) (NP (NP (NNP Hyphen) (NNP BioMed)) (, ,) (NP-LOC (NNP France))) (-RRB- -RRB-))))))) (. .)) )
( (HEADING (NP (UCP (JJ Histochemical) (CC and) (NN immunohistochemistry)) (NN analysis))) )
( (S (NP-SBJ-1 (NP (NP (DT The) (VBN frozen) (NNS tails)) (CC or) (NP (JJ injured) (NNS carotids))) (PP-LOC (IN in) (NP (NN OCT)))) (VP (VBD were) (VP (VP (VBN sectioned) (NP-1 (-NONE- *)) (PP (IN at) (NP (NML (CD 5) (NNS μm)) (NN thickness)))) (CC and) (VP (VBD stained) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (NP (NNP Masson) (POS 's)) (NN Trichrome) (PRN (-LRB- -LRB-) (NP (NN HT) (CD 15)) (, ,) (NP (NNP Sigma) (NNP Diagnostics)) (-RRB- -RRB-))))))) (. .)) )
( (S (PP-PRP (IN For) (NP (NP (JJ quantitative) (NN analysis)) (PP (IN of) (NP (NN collagen) (NN area))) (PP-LOC (IN in) (NP (DT the) (NN tail) (NNS sections))))) (, ,) (NP-SBJ-1 (NP (CD four) (NNS sections)) (PP (IN from) (NP (QP (CD 2) (SYM –) (CD 3)) (NNS sites)))) (VP (VBD were) (VP (VBN measured) (NP-1 (-NONE- *)) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (ADJP (NN computer) (VBN assisted)) (NN image) (NN analysis)) (PRN (-LRB- -LRB-) (NP (NNP Image) (HYPH -) (NNP Pro) (NNP Plus)) (, ,) (NP (NNP Cybernetics)) (-RRB- -RRB-)))))) (. .)) )
( (S (PP-PRP (IN For) (NP (NP (DT the) (NN area) (NN determination)) (PP (IN of) (NP (DT the) (JJ injured) (NN carotid) (NN lumen))))) (, ,) (NP-SBJ-1 (NP (QP (CD 3) (SYM –) (CD 4)) (NNS sections)) (PP (IN from) (NP (NP (JJ different) (NNS sites)) (ADVP (NP (QP (RB approximately) (CD 100)) (NNS μm)) (RB apart))))) (VP (VBD were) (VP (VBN analyzed) (CC and) (VBN averaged) (NP-1 (-NONE- *)) (PP (IN for) (NP (DT each) (NN mouse))))) (. .)) )
( (HEADING (NP (NN Statistics))) )
( (S (NP-SBJ-1 (NNS Data)) (VP (VBP are) (VP (VBN presented) (NP-1 (-NONE- *)) (PP (IN as) (NP (NN mean) (SYM ±) (NN SEM))))) (. .)) )
( (S (NP-SBJ-1 (NP (DT The) (JJ statistical) (NN analysis)) (PP (IN for) (NP (NP (NNS comparisons)) (PP (PP (IN between) (NP (NML (NML (NN A) (HYPH /) (NN J)) (CC and) (NML (NN B6))) (NNS mice))) (CC and) (PP (IN between) (NP (NML (NML (NML (JJ wild) (HYPH -) (NN type)) (-LRB- -LRB-) (NML (NN WT))) (-RRB- -RRB-) (CC and) (NML (NN Plg) (SYM -) (HYPH /) (SYM -))) (NNS littermates))))))) (VP (VBD was) (VP (VBN compared) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (DT a) (ADJP (CD two) (HYPH -) (VBN tailed)) (NN t) (HYPH -) (NN test))))) (. .)) )
( (S (NP-SBJ-1 (NP (NNS Differences)) (PP (IN among) (NP (NML (NML (NN B6)) (, ,) (NML (NN Lepob)) (, ,) (NML (NML (NN PAI) (HYPH -) (CD 1)) (SYM -) (HYPH /) (SYM -))) (NNS mice)))) (VP (VBD were) (VP (VBN determined) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NP (DT a) (NML (CD one) (HYPH -) (NN way)) (NN ANOVA)) (CC and) (NP (DT a) (NML (NNP Newman) (HYPH -) (NNP Keuls)) (NN post-test)))))) (. .)) )
( (S (NP-SBJ-1 (NP (DT A) (NN value)) (PP (IN of) (NP (NP (NN P)) (ADJP (SYM <) (NP (CD 0.05)))))) (VP (VBD was) (VP (VBN considered) (S (NP-SBJ-1 (-NONE- *)) (ADJP-PRD (JJ significant))))) (. .)) )
( (S (S (NP-SBJ-1=3 (NP (DT The) (JJ statistical) (NN analysis)) (PP (IN for) (NP (NP (NNS comparisons)) (PP (IN between) (NP (NP (NN B6) (NNS mice)) (CC and) (NP (NN CSS))))))) (VP (VBD were) (VP=2 (VBN determined) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (NML (CD two) (HYPH -) (NN tail)) (NN t) (HYPH -) (NNS tests)))))) (CC and) (S (NP-SBJ-4=3 (NP (DT the) (NN level)) (PP (IN of) (NP (DT the) (JJ significant) (NN P) (HYPH -) (NNS values))) (PRN (-LRB- -LRB-) (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB see) (NP (NN figure) (NNS legends)))) (-RRB- -RRB-))) (VP=2 (VBN determined) (NP-4 (-NONE- *)) (PP-MNR (IN with) (NP (NP (DT a) (NNP Bonferroni) (NN correction)) (SBAR (WHNP-5 (-NONE- *0*)) (S (NP-SBJ-5 (-NONE- *T*)) (VP (TO to) (VP (VB account) (PP (IN for) (NP (NN multihypothesis) (NN testing))))))))) (PRN (-LRB- [) (NP (CD 13)) (-RRB- ])))) (. .)) )
( (HEADING (NP (NNS Results))) )
( (HEADING (NP (NP (JJ Marked) (NNS differences)) (PP (IN in) (NP (NML (JJ arterial) (NN thrombus)) (NN formation))) (PP-LOC (IN in) (NP (NML (NML (NN B6)) (CC and) (NML (NN A) (HYPH /) (NN J))) (NNS mice))))) )
( (S (NP-SBJ-1 (NP (DT The) (NN FeCl3) (NML (JJ cartoid) (NN artery)) (NN injury) (NN model) (PRN (-LRB- [) (NP (CD 24)) (-RRB- ]))) (, ,) (NP (DT a) (ADJP (JJ well) (HYPH -) (VBN characterized)) (NML (JJ arterial) (NN thrombosis)) (NN model))) (, ,) (VP (VBD was) (VP (VBN used) (NP-1 (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB induce) (NP (DT an) (JJ occlusive) (NN thrombus)) (PP-LOC (IN in) (NP (NP (DT the) (NML (NML (NN B6)) (CC and) (NML (NN A) (HYPH /) (NN J))) (NN mouse) (NNS strains)) (PP (IN under) (NP (NN investigation)))))))))) (. .)) )
( (S (NP-SBJ-1 (NP (DT A) (JJ marked) (NN difference)) (PP (IN in) (NP (NML (NML (JJ arterial) (NN thrombus)) (NN occlusion)) (NN time)))) (VP (VBD was) (VP (VBN found) (NP-1 (-NONE- *)) (PP (IN between) (NP (NP (DT the) (NN B6) (NML-2 (-NONE- *RNR*))) (CC and) (NP (DT the) (NML (NN A) (HYPH /) (NN J)) (NML-2 (-NONE- *RNR*))) (NML-2 (NNS mice)))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 1A)) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ (NP (DT The) (NN occlusion) (NN time)) (PP-LOC (IN in) (NP (DT the) (NML (NN A) (HYPH /) (NN J)) (NNS mice)))) (VP (VBD was) (ADJP-PRD (ADJP (RB 2-fold) (JJR less)) (PP (IN than) (PP (IN for) (NP (DT the) (NN B6) (NNS mice)))))) (. .)) )
( (S (S (NP-SBJ-1 (NP (DT A) (NML (CD 5) (NN %)) (NN dose)) (PP (IN of) (NP (NN FeCl3)))) (VP (VBD was) (VP (VBN tested) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (DT the) (NML (NML (NN A) (HYPH /) (NN J)) (CC and) (NML (NN B6))) (NNS mice)))))) (CC and) (S (NP-SBJ (DT the) (NN occlusion) (NN time)) (VP (VBD was) (ADJP-PRD (ADJP (JJR lower)) (PP-LOC (IN in) (NP (DT the) (NN A) (HYPH /) (NN J) (NML-2 (-NONE- *RNR*)))) (PP (IN than) (NP (DT the) (NN B6) (NML-2 (-NONE- *RNR*))) (NML-2 (NNS mice)))) (, ,) (NP-ADV (NP (DT the) (JJ same) (NNS results)) (PP (IN as) (PP (IN with) (NP (DT the) (NML (CD 10) (NN %)) (NN dose))))))) (. .)) )
( (S (NP-SBJ (NP (DT The) (NN occlusion) (NN time) (PRN (-LRB- -LRB-) (NP (NP (NNS min)) (PP (IN for) (NP (CC both) (NP (NN B6) (PRN (-LRB- -LRB-) (NP (QP (CD 15) (SYM ±) (CD 3))) (, ,) (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP (CD 3)))) (-RRB- -RRB-))) (CC and) (NP (NN A) (HYPH /) (NN J) (PRN (-LRB- -LRB-) (NP (QP (CD 8) (SYM ±) (CD 1))) (, ,) (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP (CD 3)))) (-RRB- -RRB-)))))))) (PP (IN at) (NP (CD 5) (NN %)))) (VP (VBD were) (ADJP-PRD (ADJP (JJR longer)) (PP (IN than) (PP (IN at) (NP (CD 10) (NN %))))) (PP (IN for) (NP (NP (NN B6) (PRN (-LRB- -LRB-) (NP (QP (CD 10) (SYM ±) (CD 1))) (, ,) (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP (CD 17)))))) (CC and) (NP (NN A) (HYPH /) (NN J) (PRN (-LRB- -LRB-) (NP (QP (CD 5) (SYM ±) (CD 2))) (, ,) (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP (CD 14)))) (-RRB- -RRB-)))))) (. .)) )
( (S (S (NP-SBJ (NP (DT The) (NNS curves)) (PP (IN of) (NP (NN blood) (NN flow))) (PP-TMP (IN after) (NP (NN FeCl3) (NN application)))) (VP (VBD indicated) (NP (DT a) (NN pattern)) (PP (IN with) (NP (NP (DT a) (JJ gradual) (NN decrease)) (PP-TMP (IN before) (NP (NN occlusion))) (PP (IN for) (NP (DT the) (NN B6) (NNS mice))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 1B)) (-RRB- -RRB-)))) (, ,) (CC but) (S (PP-PRP (IN for) (NP (DT the) (NML (NN A) (HYPH /) (NN J)) (NNS mice))) (NP-SBJ (DT the) (NN blood) (NN flow)) (VP (VBD decreased) (ADVP-TMP (RB abruptly)) (PP (IN to) (NP (CD zero))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 1C)) (-RRB- -RRB-)) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG demonstrating) (NP (NP (DT a) (JJ marked) (NN difference)) (PP (IN from) (NP (DT the) (NN B6) (NN strain)))))))) (. .)) )
( (S (NP-SBJ (DT The) (JJ mean) (NN occlusion) (NNS times)) (VP (VBD were) (ADJP-PRD (RB significantly) (JJ different)) (PP (IN between) (NP (DT the) (CD two) (NNS strains))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 1A)) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ (NP (DT The) (NN size)) (PP (IN of) (NP (DT the) (NNS carotids))) (PP-LOC (IN in) (NP (DT the) (CD two) (NNS strains)))) (VP (VBD was) (ADJP-PRD (RB noticeably) (JJ different))) (. .)) )
( (S (NP-SBJ (NP (DT The) (NN area) (PRN (-LRB- -LRB-) (NP (NN mm2)) (-RRB- -RRB-))) (PP (IN of) (NP (DT the) (NN lumen) (PRN (-LRB- -LRB-) (NP (QP (CD 0.066) (SYM ±) (CD 0.007))) (, ,) (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP (CD 6)))) (-RRB- -RRB-))))) (VP (VBD was) (ADJP-PRD (ADJP (RB significantly) (JJR less)) (PP-1 (-NONE- *ICH*))) (PP-LOC (IN in) (NP (DT the) (NML (NN A) (SYM /) (NN J)) (NNS mice))) (PP-1 (IN than) (PP (IN for) (NP (NN B6) (NNS mice)))) (PRN (-LRB- -LRB-) (NP (QP (CD 0.128) (SYM ±) (CD 0.007))) (, ,) (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP (CD 6)))) (-RRB- -RRB-))) (. .)) )
( (S (ADVP (RB However)) (, ,) (NP-SBJ (NP (DT the) (NN ratio)) (PP (IN of) (NP (DT the) (NN thrombus))) (PP (IN to) (NP (NN lumen)))) (VP (VBD was) (ADJP-PRD (JJ similar)) (PP (IN for) (NP (NP (NN A) (HYPH /) (NN J) (PRN (-LRB- -LRB-) (NP (QP (CD 0.63) (SYM ±) (CD 0.03))) (-RRB- -RRB-))) (PP (VBN compared) (PP (IN to) (NP (NN B6) (NNS mice) (PRN (-LRB- -LRB-) (NP (QP (CD 0.67) (SYM ±) (CD 0.09))) (-RRB- -RRB-)))))))) (. .)) )
( (S (NP-SBJ (VBN Calculated) (NN sheer) (NN stress) (NNS rates) (PRN (-LRB- [) (NP (CD 25)) (-RRB- ]))) (VP (VBD were) (ADJP-PRD (NP (CD 14) (NN %)) (JJR less)) (PP-LOC (IN in) (NP (DT the) (NML (NN A) (HYPH /) (NN J)) (NNS mice))) (SBAR-TMP (WHADVP-1 (WRB when)) (S (NP-SBJ-2 (-NONE- *PRO*)) (VP (VBN compared) (NP-2 (-NONE- *)) (PP (IN to) (NP (NN B6) (NNS mice))) (ADVP-TMP-1 (-NONE- *T*)))))) (. .)) )
( (HEADING (NP (NN Figure) (CD 1))) )
( (HEADING (NP (NP (NML (JJ Arterial) (NN occlusion)) (NN time)) (PP-LOC (IN in) (NP (NML (NML (NN B6)) (CC and) (NML (NN A) (HYPH /) (NN J))) (NNS mice))) (. .))) )
( (CAPTION (S (NP-SBJ (NNS Panels) (NML (NN A) (CC and) (NN B))) (VP (VBP are) (NP-PRD (NP (JJ representative) (NN occlusion) (NNS curves)) (PP (IN from) (NP (DT each) (NN genotype))))) (. .))) )
( (CAPTION (S (NP-SBJ (JJ Red) (NNS arrows)) (VP (VBP indicate) (NP (NP (NN duration)) (PP (IN of) (NP (NP (NML (JJ ferric) (NN chloride)) (NN application)) (PP (IN to) (NP (DT the) (NN carotid))))))) (. .))) )
( (CAPTION (NP (NP (NP (NN Panel) (NN A)) (: :) (NP (NN B6) (NNS mice))) (, ,) (NP (NP (NN Panel) (NN B)) (: :) (NP (NML (NN A) (HYPH /) (NN J)) (NNS mice))) (. .))) )
( (CAPTION (NP (NP (NN Panel) (NN C)) (: :) (NP (NP (NML (JJ Arterial) (NN occlusion)) (NN time)) (, ,) (NP (NP (NN mean) (SYM ±) (NN SEM)) (PP (IN of) (NP (NP (QP (CD 14) (HYPH –) (CD 17)) (NNS mice)) (PP (IN per) (NP (NN genotype))))))) (. .))) )
( (CAPTION (S (NP-SBJ (NN Symbol)) (VP (VBZ indicates) (NP (NP (NP (DT a) (JJ significant) (NN difference) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (SYM **) (NN P)) (VP (SYM <) (NP (CD 0.01)))) (-RRB- -RRB-))) (PP (IN between) (NP (NN B6) (NNS mice)))) (VP (VBN determined) (NP (-NONE- *)) (PP-MNR (IN with) (NP (DT a) (NN t) (HYPH -) (NN test)))))) (. .))) )
( (HEADING (NP (NP (JJ Marked) (NNS differences)) (PP (IN in) (NP (NN rebleeding) (NN time))) (PP-LOC (IN in) (NP (NML (NML (NN B6)) (CC and) (NML (NN A) (HYPH /) (NN J))) (NNS mice))))) )
( (S (NP-SBJ-1 (NP (DT The) (NN bleeding) (NN time)) (, ,) (NP (NP (DT an) (NN indicator)) (PP (IN of) (NP (JJ hemostatic) (NN activity))))) (, ,) (VP (VBD was) (VP (VBN determined) (NP-1 (-NONE- *)) (PP-TMP (IN after) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VP (VBG prewarming) (NP (DT the) (NN tail))) (, ,) (VP (VBG clipping) (NP (DT a) (NML (CD 5) (NN mm)) (NN segment))) (, ,) (VP (VBG placing) (NP (DT the) (NN tail)) (PP-LOC (IN in) (NP (JJ warm) (NN saline)))) (CC and) (VP (VBG measuring) (NP (NP (DT the) (NN time)) (SBAR (WHADVP-2 (-NONE- *0*)) (IN for) (S (NP-SBJ (DT the) (NN bleeding)) (VP (TO to) (VP (VB stop) (ADVP-TMP-2 (-NONE- *T*))))))))))))) (. .)) )
( (S (NP-SBJ (PRP We)) (VP (VBD found) (SBAR (-NONE- *0*) (S (NP-SBJ (DT this) (NN procedure)) (VP (VP (VBD was) (ADJP-PRD (JJ consistent) (CC and) (JJ reproducible)) (PP-LOC (IN in) (NP (JJ different) (NN mouse) (NNS strains)))) (CC and) (VP (VBD was) (RB not) (ADJP-PRD (NN gender) (JJ dependent))))))) (. .)) )
( (S (NP-SBJ (NN Bleeding) (NN time)) (VP (VBD was) (RB not) (ADJP-PRD (JJ different)) (PP-LOC (IN in) (NP (NML (NN A) (HYPH /) (NN J)) (NNS mice))) (PP (VBN compared) (PP (IN to) (NP (NN B6) (NNS mice)))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 2A)) (-RRB- -RRB-))) (. .)) )
( (S (PP-PRP (IN In) (NP (NN order) (S (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB determine) (SBAR (IN if) (S (NP-SBJ-1 (JJ specific) (NNS pathways)) (VP (VBD were) (VP (VBN altered) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (DT the) (NML (NML (NN B6)) (CC and) (NML (NN A) (HYPH /) (NN J))) (NNS strains)))))))))))) (, ,) (NP-SBJ-2 (NP (NP (NP (NNS mice)) (PP (IN with) (NP (NP (JJ known) (NNS alterations)) (PP-LOC (IN in) (NP=3 (NN hemostasis)))))) (, ,) (NP=4 (NN Lepob) (NNS mice))) (, ,) (CC or) (NP (NP=3 (NN thrombosis)) (, ,) (NP=4 (NML (NML (NN Plg) (SYM -) (HYPH /) (SYM -)) (CC and) (NML (NN PAI) (SYM -) (HYPH /) (SYM -))) (NNS mice)))) (, ,) (VP (VBD were) (ADVP (RB also)) (VP (VBN tested) (NP-2 (-NONE- *)))) (. .)) )
( (S (NP-SBJ-1 (DT The) (NN Lepob) (NNS mice)) (VP (VP (VBP have) (NP (VBN impaired) (NN platelet) (NN aggregation)) (PRN (-LRB- [) (NP (CD 26)) (-RRB- ]))) (CC and) (VP (VBD were) (VP (VBN evaluated) (NP-1 (-NONE- *)) (PP (IN as) (NP (NP (DT a) (NN reference)) (PP (IN for) (NP (NN platelet) (NN function)))))))) (. .)) )
( (S (PP-LOC (IN In) (NP (DT the) (NN Lepob) (NNS mice) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 2A)) (-RRB- -RRB-)))) (NP-SBJ (EX there)) (VP (VBD was) (NP-PRD (NP (RB nearly) (DT a) (RB 10-fold) (NN increase)) (PP (IN in) (NP (NN bleeding) (NN time))) (PP (VBN compared) (PP (IN to) (NP (NN B6) (NNS mice)))))) (. .)) )
( (S (NP-SBJ-1 (NN Bleeding) (NN time)) (VP (VBD was) (ADVP (RB also)) (ADVP (RB significantly) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN P)) (VP (SYM =) (NP (CD 0.0001)))) (-RRB- -RRB-))) (VP (VBN increased) (NP-1 (-NONE- *)) (PP-EXT (IN by) (NP (CD 66) (NN %))) (PP-LOC (IN in) (NP (DT the) (NML (NN Plg) (SYM -) (HYPH /) (SYM -)) (NNS mice))) (PP (VBN compared) (PP (IN to) (NP (NN WT) (NNS mice) (NNS littermates)))))) (. .)) )
( (S (NP-SBJ (NN Bleeding) (NN time)) (VP (VBD was) (RB not) (ADJP-PRD (JJ different)) (PP-LOC (IN in) (NP (NML (NML (NN PAI) (HYPH -) (CD 1)) (SYM -) (HYPH /) (SYM -)) (NNS mice))) (PP (VBN compared) (PP (IN to) (NP (NN B6) (NNS mice))))) (. .)) )
( (S (PP (IN In) (NP (NP (NN contrast)) (PP (IN to) (NP (NP (DT the) (NN Lepob) (NNS mice)) (PP (IN with) (NP (NP (DT a) (NN platelet) (NN defect)) (CC and) (NP (NP (RB 10-fold) (NN increase)) (PP (IN in) (NP (NN bleeding) (NN time)))))))))) (, ,) (S (S (NP-SBJ (EX there)) (VP (VBD was) (NP-PRD (NP (DT no) (NN difference)) (PP (IN in) (NP (NP (DT the) (NN bleeding) (NN time)) (PP (IN between) (NP (NML (NML (NN B6)) (CC and) (NML (NN A) (HYPH /) (NN J))) (NNS mice)))))))) (CC and) (S (NP-SBJ (-NONE- *PRO*)) (VP (VBD suggested) (SBAR (-NONE- *0*) (S (NP-SBJ-1 (NN platelet) (NN aggregation)) (VP (VBZ is) (RB not) (VP (VBN altered) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (DT these) (CD two) (NNS strains)))))))))) (. .)) )
( (HEADING (NP (NN Figure) (CD 2))) )
( (HEADING (NP (NP (NML (NN Bleeding) (CC and) (NN rebleeding)) (NN time)) (PP-LOC (IN in) (NP (NML (NML (NN B6)) (, ,) (NML (NN A) (HYPH /) (NN J)) (, ,) (NML (NNP Lepob)) (, ,) (NML (NN Plg) (SYM -) (HYPH /) (SYM -)) (CC and) (NML (NML (NN PAI) (HYPH -) (CD 1)) (SYM -) (HYPH /) (SYM -))) (NNS mice))) (. .))) )
( (CAPTION (FRAG (FRAG (NP (NN Panel) (NML (NN A) (, ,) (NN B))) (: :) (NP (NN Bleeding) (NN time) (PRN (-LRB- -LRB-) (NP (NNS seconds)) (-RRB- -RRB-)))) (CC and) (FRAG (NP (NN Panel) (NML (NN C) (, ,) (NN D))) (: :) (NP (NN Rebleeding) (NN time) (PRN (-LRB- -LRB-) (NP (NNS seconds)) (-RRB- -RRB-)))) (. .))) )
( (CAPTION (S (S (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO To) (VP (VB determine) (NP (JJ statistical) (NNS differences))))) (, ,) (NP-SBJ-2 (NP (NNS values)) (PP (PP (IN from) (NP (NML (NML (NN B6)) (CC and) (NML (NN A) (HYPH /) (NN J))) (NML-1 (-NONE- *RNR*)))) (CC and) (PP (IN from) (NP (NML (NML (NN WT)) (CC and) (NML (NN Plg) (SYM -) (HYPH /) (SYM -))) (NML-1 (-NONE- *RNR*)))) (NML-1 (NNS littermates)))) (VP (VBD were) (VP (VBN compared) (NP-2 (-NONE- *)) (PP-MNR (IN with) (NP (DT a) (NN t) (HYPH -) (NN test)))))) (, ,) (CC and) (S (NP-SBJ-3 (NP (NNS values)) (PP (IN from) (NP (NP (NN B6)) (, ,) (NP (NML (NN PAI) (HYPH -) (CD 1)) (SYM -) (HYPH /) (SYM -)) (CC and) (NP (NN Lepob))))) (VP (VBD were) (VP (VBN compared) (NP-3 (-NONE- *)) (PP-MNR (IN by) (NP (NP (DT a) (NML (CD one) (HYPH -) (NN way)) (NN ANOVA)) (CC and) (NP (DT a) (NML (NNP Newman) (HYPH -) (NNP Keuls)) (NN post-test))))))) (. .))) )
( (CAPTION (S (NP-SBJ (NNS Symbols)) (VP (VBP indicate) (NP (NP (DT a) (JJ significant) (NN difference) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (SYM *) (NN P)) (VP (SYM <) (NP (CD 0.05)))) (, ,) (S-FRM (NP-SBJ (SYM **) (NN P)) (VP (SYM <) (NP (CD 0.01)))) (, ,) (S-FRM (NP-SBJ (SYM ***) (NN P)) (VP (SYM <) (NP (CD 0.001)))) (-RRB- -RRB-))) (PP (IN between) (NP (NML (NN B6) (CC or) (NN WT)) (NNS mice))))) (. .))) )
( (CAPTION (S (NP-SBJ (NNS Values)) (VP (VBP are) (NP-PRD (NP (DT the) (NN mean) (SYM ±) (NN SEM)) (PP (IN of) (NP (NP (QP (CD 10) (SYM –) (CD 34)) (NNS mice)) (PP (IN per) (NP (NN genotype))))))) (. .))) )
( (S (NP-SBJ-1 (NP (NN Rebleeding) (NN time)) (, ,) (NP (NP (DT an) (NN indicator)) (PP (IN of) (NP (NN thrombus) (NN stability))))) (, ,) (VP (VBD was) (VP (VBN measured) (NP-1 (-NONE- *)) (PP (IN as) (NP (NP (DT the) (NN time)) (PP (IN between) (NP (NP (NP (DT the) (NN cessation)) (PP (IN of) (NP (NN bleeding)))) (CC and) (NP (NP (DT the) (NN start)) (PP (IN of) (NP (DT the) (JJ second) (NN bleeding)))))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 2B)) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ (NN Rebleeding) (NNS times)) (VP (VBD were) (ADJP-PRD (ADJP (RB significantly) (JJR higher)) (PP-1 (-NONE- *ICH*))) (PP-LOC (IN in) (NP (NML (NN A) (HYPH /) (NN J) (PRN (-LRB- -LRB-) (NP (RB 2.6-fold)) (, ,) (S-FRM (NP-SBJ (NN P)) (VP (SYM <) (NP (CD 0.001)))) (-RRB- -RRB-))) (NNS mice))) (PP-1 (IN than) (NP (DT the) (NN B6) (NNS mice)))) (. .)) )
( (S (PP (IN In) (NP (NN contrast))) (, ,) (NP-SBJ (DT the) (NN rebleeding) (NN time)) (VP (VBD was) (ADJP-PRD (ADJP (QP (RB nearly) (RB 8.5-fold)) (JJR less)) (PP-1 (-NONE- *ICH*))) (PP-LOC (IN in) (NP (DT the) (NN Lepob) (NNS mice))) (PP-1 (IN than) (NP (DT the) (NN B6) (NNS mice)))) (. .)) )
( (S (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO To) (VP (VB determine) (SBAR (WHADVP-1 (WRB how)) (S (NP-SBJ (NP (NNS alterations)) (PP (IN in) (NP (DT the) (JJ fibrinolytic) (NN system)))) (VP (MD may) (VP (VB affect) (NP (NN rebleeding) (NN time)) (ADVP-MNR-1 (-NONE- *T*))))))))) (, ,) (NP-SBJ-2 (NML (NML (NN Plg) (SYM -) (HYPH /) (SYM -)) (CC and) (NML (NML (NN PAI) (HYPH -) (CD 1)) (SYM -) (HYPH /) (SYM -))) (NNS mice)) (VP (VBD were) (RB also) (VP (VBN tested) (NP-2 (-NONE- *)) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 2B)) (-RRB- -RRB-)))) (. .)) )
( (S (S (NP-SBJ (VBG Rebleeding) (NN time)) (VP (VBD was) (RB not) (ADJP-PRD (JJ different)) (PP-LOC (IN in) (NP (NML (NN Plg) (SYM -) (HYPH /) (SYM -)) (NNS mice))) (PP (VBN compared) (PP (IN to) (NP (NN WT) (NNS littermates)))))) (, ,) (CC but) (S (NP-SBJ (NML (NML (NN PAI) (HYPH -) (CD 1)) (SYM -) (HYPH /) (SYM -)) (NNS mice)) (VP (VBD had) (NP (NP (DT a) (ADJP (ADVP (RB significantly) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN P)) (VP (SYM <) (NP (CD 0.05)))) (-RRB- -RRB-))) (VBN reduced)) (NN rebleeding) (NN time)) (, ,) (SBAR (WHNP-1 (WDT which)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBD was) (ADJP-PRD (ADJP (RB 1.8-fold) (JJR lower)) (PP (IN than) (PP (IN for) (NP (DT the) (NN B6) (NNS mice))))))))))) (. .)) )
( (S (SBAR-ADV (IN Although) (S (NP-SBJ (DT a) (NN Plg) (NN deficiency)) (VP (VBD did) (RB not) (VP (VB result) (PP (IN in) (NP (DT a) (JJ prolonged) (NN rebleeding) (NN time))) (SBAR-ADV (IN as) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN anticipated) (NP-1 (-NONE- *))))))))) (, ,) (NP-SBJ (DT a) (NML (NN PAI) (HYPH -) (CD 1)) (NN deficiency)) (VP (VBD resulted) (PP (IN in) (NP (DT a) (VBN shortened) (NN time)))) (. .)) )
( (S (NP-SBJ (NP (DT The) (ADJP (RB markedly) (VBN increased)) (NN rebleeding) (NN time)) (PP-LOC (IN in) (NP (DT the) (NN A) (HYPH /) (NN J)))) (VP (MD may) (VP (VB suggest) (NP (NP (NNS differences)) (PP (IN in) (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (DT the) (NN Plg) (NN network)))))))) (. .)) )
( (HEADING (NP (NP (DT No) (NN difference)) (PP (IN in) (NP (NN blood) (NN coagulation))) (PP (IN between) (NP (NML (NML (NN B6)) (CC and) (NML (NN A) (HYPH /) (NN J))) (NNS mice))))) )
( (S (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO To) (VP (VB determine) (SBAR (IN if) (S (NP-SBJ (NP (NNS differences)) (PP (IN in) (NP (NN coagulation)))) (VP (VBD were) (NP-PRD (NP (VBG contributing) (NNS factors)) (PP (IN to) (NP (DT the) (NML (NN bleeding) (CC and) (NN rebleeding)) (NNS results)))))))))) (, ,) (NP-SBJ-1 (NP (NP (NN prothrombin) (NN time)) (-LRB- -LRB-) (NP (NN PT))) (-RRB- -RRB-) (CC and) (NP (NP (VBN activated) (JJ partial) (NN thromboplastin) (NN time)) (-LRB- -LRB-) (NP (NN aPTT)))) (-RRB- -RRB-) (VP (VBD were) (VP (VBN measured) (NP-1 (-NONE- *)))) (. .)) )
( (S (NP-SBJ (NN PT)) (VP (VBZ is) (NP-PRD (NP (DT a) (NN measurement)) (PP (IN of) (NP (NP (DT the) (JJ extrinsic) (NN coagulation) (NN pathway)) (-LRB- -LRB-) (NP (NP (NN activation)) (PP (IN of) (NP (NN Factor) (CD VII))) (PP (IN by) (NP (NN tissue) (NN factor))))))) (-RRB- -RRB-) (SBAR-ADV (IN while) (S (NP-SBJ (NN aPTT)) (VP (VBZ is) (NP-PRD (NP (DT a) (NN measurement)) (PP (IN of) (NP (NP (DT the) (JJ intrinsic) (NN pathway)) (-LRB- -LRB-) (NP (NP (NN activation)) (PP (IN of) (NP (NNS Factors) (NML (CD XII) (, ,) (CD XI) (, ,) (CD IX) (CC and) (CD VIII)))))))))))) (-RRB- -RRB-) (. .)) )
( (S (NP-SBJ (NP (DT The) (NNS products)) (PP (IN of) (NP (DT both) (NNS pathways)))) (VP (VBP activate) (NP (NP (NN Factor) (CD X)) (, ,) (SBAR (WHNP-1 (WDT which)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBZ initiates) (NP (NP (DT the) (JJ common) (NN pathway)) (VP (VBG leading) (PP (IN to) (NP (NP (NN thrombin) (NN generation)) (CC and) (NP (NML (NN fibrin) (NN clot)) (NN formation))))))))))) (. .)) )
( (S (S (NP-SBJ-1 (NN PT) (CC and) (NN aPTT)) (VP (VBD were) (VP (VBN measured) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (DT the) (NML (NML (NN B6)) (CC and) (NML (NN A) (HYPH /) (NN J))) (NNS mice)))))) (CC and) (S (NP-SBJ (NNS values)) (VP (VBD were) (RB not) (ADJP-PRD (JJ different) (PP (IN between) (NP (DT the) (CD two) (NN mouse) (NNS strains)))) (PRN (-LRB- -LRB-) (NP (NN Table) (CD 2)) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ (DT These) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (NP-SBJ (DT the) (NN coagulation) (NN pathway)) (VP (VBZ is) (RB not) (ADJP-PRD (JJ different)) (PP-LOC (IN in) (NP (DT the) (CD two) (JJ inbred) (NNS strains))))))) (. .)) )
( (HEADING (NP (NN Table) (CD 2))) )
( (HEADING (NP (NP (NML (NN Coagulation) (CC and) (NN Plasminogen)) (NN System) (NNS Parameters)) (PP-LOC (IN in) (NP (NML (NML (NN B6)) (CC and) (NML (NN A) (HYPH /) (NN J))) (JJ inbred) (NN mouse) (NNS strains))))) )
( (CAPTION (S (NP-SBJ (NNS Values)) (VP (VBP are) (NP-PRD (DT the) (NN mean) (SYM ±) (NN SEM))) (. .))) )
( (CAPTION (S (S-FRM (NP-SBJ (SYM *) (NN P)) (VP (SYM <) (NP (CD 0.05)))) (, ,) (S-FRM (NP-SBJ (SYM **) (NN P)) (VP (SYM <) (NP (CD 0.01)))) (. .))) )
( (CAPTION (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP (QP (CD 5) (SYM –) (CD 8)))) (. .))) )
( (HEADING (FRAG (NP-SBJ (NP (NN Plg)) (CC and) (NP (NN PAI) (HYPH -) (CD 1))) (ADJP-PRD (ADJP (JJR higher)) (PP-1 (-NONE- *ICH*))) (PP-LOC (IN in) (NP (NN A) (HYPH /) (NN J))) (PP-1 (IN than) (NP (NN B6) (NNS mice))))) )
( (S (NP-SBJ (NN Plg) (NN concentration)) (VP (VBD was) (ADJP-PRD (ADJP (NP (CD 34) (NN %)) (JJR higher)) (PP-1 (-NONE- *ICH*))) (PP-LOC (IN in) (NP (DT the) (NML (NN A) (HYPH /) (NN J)) (NNS mice))) (PP-1 (IN than) (PP-LOC (IN in) (NP (NN B6) (NNS mice))))) (. .)) )
( (S (PP (IN In) (NP (NN addition))) (, ,) (NP-SBJ-1 (NP (JJ fibrinolytic) (NN activity)) (, ,) (NP (NML (NN PAI) (HYPH -) (CD 1)) (NN activity)) (, ,) (CC and) (NP (NN α2) (HYPH -) (NN anitplasmin))) (VP (VBD were) (RB also) (VP (VBN increased) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (DT the) (NML (NN A) (SYM /) (NN J)) (NNS mice))) (SBAR-TMP (WHADVP-2 (WRB when)) (S (NP-SBJ-3 (-NONE- *PRO*)) (VP (VBN compared) (NP-3 (-NONE- *)) (PP (IN to) (NP (DT the) (NN B6) (NNS mice))) (ADVP-TMP-2 (-NONE- *T*))))) (PRN (-LRB- -LRB-) (NP (NN Table) (CD 2)) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ (NP (DT The) (JJ functional) (NNS consequences)) (PP (IN of) (NP (DT these) (NNS differences)))) (VP (VBP are) (RB not) (ADJP-PRD (JJ clear)) (, ,) (SBAR-PRP (IN since) (S (NP-SBJ (NN fibrinogen)) (VP (VBZ is) (RB also) (ADJP-PRD (JJR higher)) (PP-LOC (IN in) (NP (DT the) (NML (NN A) (HYPH /) (NN J)) (NNS mice))))))) (. .)) )
( (S (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO To) (VP (VB determine) (SBAR (IN whether) (S (NP-SBJ (EX there)) (VP (VBD were) (NP-PRD (NP (NML (NN protein) (NN structure)) (NNS changes)) (PP (IN of) (NP (NN Plg))) (PP (IN from) (NP (DT the) (NML (NN A) (HYPH /) (NN J)) (NNS mice)))))))))) (, ,) (NP-SBJ-2 (NP (NN plasma)) (PP (IN from) (NP (NP (DT the) (NN B6) (NML-1 (-NONE- *RNR*))) (CC and) (NP (DT the) (NML (NN A) (HYPH /) (NN J)) (NML-1 (-NONE- *RNR*))) (NML-1 (NNS mice))))) (VP (VBD were) (VP (VBN subjected) (NP-2 (-NONE- *)) (PP (IN to) (NP (NN electrophoresis))) (PP-MNR (IN under) (NP (ADJP (VBN reduced) (, ,) (JJ non-reduced) (, ,) (CC and) (VBG non-denaturing)) (NNS conditions))))) (. .)) )
( (S (NP-SBJ-2 (NP (DT No) (NN difference)) (PP (IN in) (NP (NN migration))) (PP (IN for) (NP (VBN immunostained) (NN Plg))) (PP (IN under) (NP (DT these) (NNS conditions)))) (VP (VBD was) (VP (VBN observed) (NP-2 (-NONE- *)) (PRN (-LRB- -LRB-) (S (NP-SBJ-1 (NNS data)) (RB not) (VP (VBN shown) (NP-1 (-NONE- *)))) (-RRB- -RRB-)))) (. .)) )
( (S (S (NP-SBJ-1 (NP (DT The) (NN density)) (PP (IN of) (NP (NP (DT the) (NNP Western) (NN blot)) (PP (IN from) (NP (NN SDS) (HYPH -) (NN PAGE))))) (PP (IN under) (NP (NP (NN reducing) (NNS conditions)) (PP (IN of) (NP (NP (NN plasma)) (PP (IN of) (NP (VBG varying) (NNS volumes))) (PP (IN from) (NP (NML (NML (NN B6)) (CC and) (NML (NN A) (HYPH /) (NN J))) (NNS mice)))))))) (VP (VBD was) (VP (VBN compared) (NP-1 (-NONE- *))))) (CC and) (S (NP-SBJ (NP (DT the) (NN density)) (PP (IN of) (NP (DT the) (NNS bands)))) (VP (VBD was) (ADJP-PRD (ADJP (NP (CD 56) (NN %)) (JJR higher)) (PP-4 (-NONE- *ICH*))) (PP-LOC (IN in) (NP (DT the) (NN A) (HYPH /) (NN J) (NML-3 (-NONE- *RNR*)))) (PP-4 (IN than) (NP (DT the) (NN B6) (NML-3 (-NONE- *RNR*)))) (NML-3 (NNS mice)) (PRN (-LRB- -LRB-) (S (NP-SBJ-2 (CD six) (JJ individual) (NNS mice)) (VP (VBD were) (VP (VBN tested) (NP-2 (-NONE- *)) (PP-TMP (IN on) (NP (QP (RB at) (RBS least) (CD two)) (NNS occasions)))))) (-RRB- -RRB-)) (PP (IN from) (NP (NP (DT the) (JJ same) (NN amount)) (PP (IN of) (NP (NN plasma))))) (PRN (-LRB- -LRB-) (NP (NN Fig.) (NN 1B)) (-RRB- -RRB-)))) (. .)) )
( (S (S (ADVP (RB Thus)) (, ,) (NP-SBJ (NP (DT the) (NN concentration)) (PP (IN of) (NP (NN Plg))) (PP-LOC (IN in) (NP (NP (NN plasma)) (PP (IN from) (NP (DT the) (NML (NN A) (HYPH /) (NN J)) (NNS mice)))))) (VP (VBD was) (ADJP-PRD (ADJP (JJR higher)) (PP (IN than) (NP (NP (NN plasma)) (PP (IN from) (NP (DT the) (NN B6) (NNS mice)))))) (SBAR-ADV (IN as) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN determined) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (CD two) (NNS methods)))))))) (CC and) (S (NP-SBJ (NP (DT no) (NN difference)) (PP (IN in) (NP (NN migration))) (PP-TMP (IN after) (NP (NN electrophoresis)))) (VP (VBD was) (VP (VBN observed) (NP-2 (-NONE- *)) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG suggesting) (NP (NP (DT no) (JJ marked) (NNS changes)) (PP (IN in) (NP (NP (DT the) (NN structure)) (PP (IN of) (NP (NN Plg))))) (PP-LOC (IN in) (NP (DT the) (CD two) (NN mouse) (NNS strains))))))))) (. .)) )
( (HEADING (NP (NP (NN Tail) (NN morphology)) (PP-LOC (IN in) (NP (NP (NN B6)) (CC and) (NP (NN A) (HYPH /) (NN J)))))) )
( (S (NP-SBJ-1 (NP (DT The) (NNS tails)) (PP (IN of) (NP (DT the) (NNS mice)))) (VP (VBD were) (VP (VBN examined) (NP-1 (-NONE- *)) (PP (IN for) (NP (NP (NNS differences)) (SBAR (WHNP-2 (WDT that)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (MD might) (VP (VB account) (PP (IN for) (NP (NP (DT the) (NNS variations)) (PP (IN in) (NP (DT the) (NML (NN bleeding) (CC and) (NN rebleeding)) (NNS values))))))))))))) (. .)) )
( (S (S (NP-SBJ-1 (NP (NNS Sections)) (PP (IN of) (NP (NP (DT the) (NN tail)) (PP (IN from) (NP (DT the) (NML (NML (NN B6)) (CC and) (NML (NN A) (HYPH /) (NN J))) (NNS mice)))))) (VP (VBD were) (VP (VBN stained) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (NP (NN Hematoxylin) (HYPH /) (NN Eosin)) (CC or) (NP (NP (NNP Masson) (POS 's)) (NN Trichrome))))))) (CC and) (S (NP-SBJ-2 (JJ representative) (NNS sections)) (VP (VBP are) (VP (VBN shown) (NP-2 (-NONE- *)) (PP (IN in) (NP (NN Figure) (CD 3)))))) (. .)) )
( (S (NP-SBJ-1 (DT No) (JJ obvious) (JJ qualitative) (NNS differences)) (VP (VBD were) (VP (VBN observed) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NP (NN hair) (NNS follicles)) (, ,) (NP (JJ sebaceous) (NNS glands)) (, ,) (CC or) (NP (NP (NN center) (NN bone)) (HYPH /) (NP (NN cartilage))))) (PP-LOC (IN in) (NP (ADJP (NP (NN Hematoxylin) (HYPH /) (NN Eosin) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 3A)) (-RRB- -RRB-))) (VBN stained)) (NNS sections))))) (. .)) )
( (S (NP-SBJ-1 (NP (NNS Sections)) (PP (IN of) (NP (DT the) (NNS tails)))) (VP (VBD were) (VP (VBN stained) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (NP (NP (NNP Masson) (POS 's)) (NN Trichrome) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 3B)) (-RRB- -RRB-))) (SBAR (WHNP-2 (WDT that)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBZ detects) (NP (NP (NN collagen)) (, ,) (NP (NP (DT the) (JJ major) (NML (NN platelet) (JJ adhesive)) (NN substratum)) (PP (IN for) (NP (NP (NN initiation)) (PP (IN of) (NP (NN thrombus) (NN formation)))))))))))))) (. .)) )
( (S (NP-SBJ-1 (NN Collagen) (NN content) (PRN (-LRB- -LRB-) (NP (NN %) (NN tail) (NN area)) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN quantified) (NP-1 (-NONE- *)) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 3C)) (-RRB- -RRB-)) (PP (IN from) (NP (NP (QP (CD 3) (SYM –) (CD 4)) (NNS sections)) (PP (IN from) (NP (NP (QP (CD 2) (SYM –) (CD 3)) (NNS areas)) (PP (SYM /) (NP (NN mouse))))))))) (. .)) )
( (S (NP-SBJ (NP (DT The) (NN amount)) (PP (IN of) (NP (NN collagen)))) (VP (VBD was) (ADJP-PRD (ADJP (JJR greater)) (PP-1 (-NONE- *ICH*))) (PP-LOC (IN in) (NP (DT the) (NN A) (HYPH /) (NN J))) (PP-1 (IN than) (NP (DT the) (NN B6) (NNS mice))) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN P)) (VP (SYM <) (NP (CD 0.05)))) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ-1 (NP (NN Collagen)) (PP-LOC (IN in) (NP (NP (NNS vessels)) (PP-LOC (IN in) (NP (NP (NN adipose) (NN tissue)) (PP-LOC (IN in) (NP (DT the) (NML (NN A) (HYPH /) (NN J)) (NNS mice)))))))) (VP (VBZ is) (ADVP (RB also)) (VP (VBN increased) (NP-1 (-NONE- *)) (PP (VBN compared) (PP (IN to) (NP (DT the) (NN B6) (NNS mice)))) (PRN (-LRB- -LRB-) (S (NP-SBJ-2 (NNS data)) (RB not) (VP (VBN shown) (NP-2 (-NONE- *)))) (-RRB- -RRB-)))) (. .)) )
( (HEADING (NP (NN Figure) (CD 3))) )
( (HEADING (NP (NP (NN Tail) (NN morphology)) (CC and) (NP (NN collagen)) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NNS Tails)) (VP (VBD were) (VP (VP (VBN excised) (NP-1 (-NONE- *))) (, ,) (VP (VBN embedded) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NN OCT)))) (, ,) (VP (VBN sectioned) (NP-1 (-NONE- *))) (, ,) (CC and) (VP (VBD stained) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (NP (NN Hematoxylin) (HYPH /) (NN Eosin)) (CC or) (NP (NP (NNP Masson) (POS 's)) (NN Trichrome))))))) (. .))) )
( (CAPTION (NP (NP (NN Panel) (NN A)) (: :) (NP (NP (NP (JJ Representative) (NNS sections)) (VP (VBN stained) (NP (-NONE- *)) (PP-MNR (IN with) (NP (NN hematoxylin) (CC and) (NN eosin))))) (PP (IN from) (NP (NML (NML (NN B6)) (CC and) (NML (NN A) (HYPH /) (NN J))) (NNS mice)))) (. .))) )
( (CAPTION (NP (NP (NN Panel) (NN B)) (: :) (NP (NP (NP (JJ Representative) (NNS sections)) (VP (VBN stained) (NP (-NONE- *)) (PP-MNR (IN with) (NP (NP (NNP Masson) (POS 's)) (NN Trichrome))))) (PP (IN from) (NP (NML (NML (NN B6)) (CC and) (NML (NN A) (HYPH /) (NN J))) (NNS mice)))) (. .))) )
( (CAPTION (S (NP-SBJ (DT The) (JJ blue) (NN color)) (VP (VBZ identifies) (NP (DT the) (NN collagen))) (. .))) )
( (CAPTION (FRAG (NP (NN Panel) (NN C)) (: :) (S (NP-SBJ-1 (NP (DT The) (NN percentage)) (PP (IN of) (NP (NP (DT the) (NN collagen) (NN area)) (-LRB- -LRB-) (VP (VBG excluding) (NP (NP (NN center) (NN bone)) (HYPH /) (NP (NN cartilage)))))) (-RRB- -RRB-) (PP (IN of) (NP (NP (DT the) (JJ total) (NN tail) (NN area)) (PP (IN of) (NP (DT each) (NN section)))))) (VP (VBD was) (VP (VP (VBN determined) (NP-1 (-NONE- *)) (PP (IN in) (NP (QP (CD 3) (SYM –) (CD 4)) (NNS sections))) (PP-LOC (IN at) (NP (NP (QP (CD 2) (SYM –) (CD 3)) (NNS sites)) (PP (IN for) (NP (DT each) (NN tail)))))) (CC and) (VP (VBD averaged) (NP-1 (-NONE- *)) (PP (IN for) (NP (DT each) (NN mouse))))))) (. .))) )
( (CAPTION (S (NP-SBJ (NNS Values)) (VP (VBP are) (NP-PRD (NP (DT the) (NN mean) (SYM ±) (NN SEM)) (PP (IN of) (NP (NP (QP (CD 4) (SYM –) (CD 8)) (NNS mice)) (PP (IN per) (NP (NN genotype))))))) (. .))) )
( (CAPTION (S (NP-SBJ (NN Symbol)) (VP (VBZ indicates) (NP (NP (NP (DT a) (JJ significant) (NN difference) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (SYM *) (NN P)) (VP (SYM <) (NP (CD 0.05)))) (-RRB- -RRB-))) (PP (IN between) (NP (NN B6) (NNS mice)))) (VP (VBN determined) (NP (-NONE- *)) (PP (IN by) (NP-LGS (NN t) (HYPH -) (NN test)))))) (. .))) )
( (HEADING (S (NP-SBJ (NML (NN Tail) (NN bleeding)) (NN assay)) (VP (VBZ identifies) (NP (NP (CD three) (NNS chromosomes)) (PP (IN with) (NP (NP (NN QTL)) (PP (IN for) (NP (NN rebleeding)))))) (PP-LOC (IN in) (NP (NN CSS)))))) )
( (S (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG Using) (NP (DT the) (NML (NN tail) (NML (NN bleeding) (HYPH /) (NN rebleeding))) (NN assay)) (PP (IN as) (NP (NP (DT a) (JJ surrogate) (NN marker)) (PP (IN for) (NP (NN hemostasis) (CC and) (NN thrombosis))))))) (, ,) (NP-SBJ-1 (DT the) (NN CSS)) (VP (VBD were) (VP (VBN screened) (NP-1 (-NONE- *)))) (. .)) )
( (S (S (NP-SBJ (NP (DT The) (NN bleeding) (NNS times) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 4A)) (-RRB- -RRB-))) (PP (IN for) (NP (NP (DT the) (NN B6) (NML-2 (-NONE- *RNR*))) (CC and) (NP (DT the) (NML (NN A) (HYPH /) (NN J)) (NML-2 (-NONE- *RNR*))) (NML-2 (NNS mice))))) (VP (VBD were) (RB not) (ADJP-PRD (JJ different)))) (, ,) (CC but) (S (NP-SBJ (NP (NP (NN 6six)) (PP (IN of) (NP (DT the) (NNS strains)))) (, ,) (NP (NP (NN B6) (HYPH -) (NN Chr5)) (, ,) (NP (CD 6)) (, ,) (NP (CD 8)) (, ,) (NP (CD 14)) (, ,) (NP (CD 15)) (, ,) (CC and) (NP (NN YA) (HYPH /) (NN J)))) (, ,) (VP (VBD had) (NP (NP (ADJP (JJR lower) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN P)) (VP (SYM <) (NP (CD 0.002)))) (-RRB- -RRB-))) (NN bleeding) (NNS times)) (-LRB- -LRB-) (NP (QP (CD 49) (SYM –) (CD 79)) (NNS seconds))) (-RRB- -RRB-) (PP (VBN compared) (PP (IN to) (NP (NP (NP (DT the) (NN value)) (PP (IN for) (NP (DT the) (NN B6) (NNS mice)))) (-LRB- -LRB-) (NP (CD 121) (NN sec))))))) (-RRB- -RRB-) (. .)) )
( (S (S (NP-SBJ-1 (NP (DT The) (NN rebleeding) (NN time) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 4B)) (-RRB- -RRB-))) (, ,) (VP (VBN determined) (NP (-NONE- *)) (PP (IN as) (NP (NP (DT the) (NN time)) (PP-TMP (IN between) (NP (NP (NN bleeding) (NN cessation)) (CC and) (NP (NP (NN initiation)) (PP (IN of) (NP (DT the) (JJ second) (NN bleeding)))))))))) (, ,) (VP (VBD was) (ADVP (RB markedly)) (VP (VBN increased) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (DT the) (NML (NN A) (HYPH /) (NN J)) (NNS mice))) (PP (VBN compared) (PP (IN to) (NP (DT the) (NN B6) (NNS mice))))))) (CC and) (S (NP-SBJ (NP (CD two) (NNS strains)) (, ,) (NP (NP (NP (NML (NN B6) (HYPH -) (NN Chr11A)) (HYPH /) (NN J)) (-LRB- -LRB-) (NP (NN CSS) (HYPH -) (CD 11))) (-RRB- -RRB-) (CC and) (NP (NP (NML (NN B6) (HYPH -) (NN Chr17A)) (HYPH /) (NN J)) (-LRB- -LRB-) (NP (NN CSS) (HYPH -) (CD 17))))) (-RRB- -RRB-) (, ,) (VP (VBD had) (NP (ADJP (ADVP (RB significantly) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN P)) (VP (SYM <) (NP (CD 0.002)))) (-RRB- -RRB-))) (JJR longer)) (NN rebleeding) (NNS times)) (PP (VBN compared) (PP (IN to) (NP (NP (DT the) (NN B6) (NNS mice)) (SBAR (WHNP-2 (WDT that)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBD were) (ADJP-PRD (JJ similar) (PP (IN to) (NP (NP (NNS values)) (PP (IN from) (NP (DT the) (NML (NN A) (HYPH /) (NN J)) (NNS mice)))))))))))))) (. .)) )
( (S (NP-SBJ (NP (DT Another) (NN strain)) (, ,) (NP (NP (NML (NN B6) (HYPH -) (NN Chr5A)) (HYPH /) (NN J)) (-LRB- -LRB-) (NP (NN CSS) (HYPH -) (CD 5)))) (-RRB- -RRB-) (, ,) (VP (VBN approached) (NP (NN significance)) (PP (IN at) (NP (NP (NN P)) (ADJP (SYM <) (NP (CD 0.008)))))) (. .)) )
( (FRAG (S (S (NP-SBJ-1=4 (DT The) (NN rebleeding) (NN time)) (VP (VBD was) (VP=3 (VBN stopped) (NP-1 (-NONE- *)) (PP-TMP (IN at) (NP (CD 600) (NN sec)))))) (, ,) (CC and) (S (NP-SBJ-2=4 (NP (DT the) (NN percentage)) (PP (IN of) (NP (NP (NNS mice)) (PP (IN with) (NP (DT this) (NN value)))))) (VP=3 (VBN determined) (NP-2 (-NONE- *)) (PP (IN for) (NP (DT the) (CD three) (NNS strains)))))) (: :) (FRAG (FRAG (NP (NN CSS) (HYPH -) (CD 5)) (: –) (NP (CD 60) (NN %))) (, ,) (FRAG (NP (NN CSS) (HYPH -) (CD 11)) (: –) (NP (NN 60) (NN %))) (CC and) (FRAG (NP (NN CSS) (HYPH -) (NN A17)) (: –) (NP (CD 46) (NN %)))) (. .)) )
( (S (S (NP-SBJ (NP (DT The) (NN percentage)) (PP (IN of) (NP (NN B6) (NNS mice))) (PP (IN with) (NP (NP (DT a) (NN rebleeding) (NN time)) (PP (IN of) (NP (CD 600) (NN sec)))))) (VP (VBD was) (NP-PRD (CD 7) (NN %)))) (CC and) (S (PP (IN for) (NP (DT the) (NML (NN A) (HYPH /) (NN J)) (NNS mice))) (NP-SBJ (DT the) (NN percentage)) (VP (VBD was) (NP-PRD (CD 85) (NN %)))) (. .)) )
( (HEADING (NP (NN Figure) (CD 4))) )
( (HEADING (NP (NP (NML (NN Bleeding) (CC and) (NN rebleeding)) (NN time)) (PP-LOC (IN in) (NP (DT the) (NN CSS))) (. .))) )
( (CAPTION (NP (NP (NN Panel) (NN A)) (: :) (NP (NN Bleeding) (NN Time) (PRN (-LRB- -LRB-) (NP (NNS seconds)) (-RRB- -RRB-))) (. .))) )
( (CAPTION (NP (NP (NN Panel) (NN B)) (: :) (NP (NN Rebleeding) (NN Time) (PRN (-LRB- -LRB-) (NP (NNS seconds)) (-RRB- -RRB-))) (. .))) )
( (CAPTION (S (NP-SBJ (NNS Bars)) (VP (VBP are) (NP-PRD (NP (DT the) (NN mean) (SYM ±) (NN SEM)) (PP (IN of) (NP (QP (CD 7) (SYM –) (CD 28)) (NNS mice))))) (. .))) )
( (CAPTION (S (S (NP-SBJ-1 (NP (JJ Statistical) (NNS differences)) (PP (IN between) (NP (NP (NN B6) (NNS mice)) (CC and) (NP (NN CSS))))) (VP (VBD were) (VP (VBN determined) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (DT a) (NN t) (HYPH -) (NN test)))))) (, ,) (CC and) (S (NP-SBJ-2 (DT a) (NNP Bonferroni) (NN correction)) (VP (VBD was) (VP (VBN made) (NP-2 (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB determine) (NP (NN significance) (NN value) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN P)) (VP (SYM <) (NP (CD 0.002)))) (-RRB- -RRB-))))))))) (. .))) )
( (CAPTION (S (NP-SBJ (NNS Symbols)) (VP (VBP indicate) (NP (NP (DT a) (JJ significant) (NN difference)) (PP (IN between) (NP (NN B6) (NNS values))))) (. .))) )
( (CAPTION (S-FRM (NP-SBJ (SYM *) (NN P)) (VP (SYM <) (NP (CD 0.002))) (. .))) )
( (S (NP-SBJ-1 (NP (NN Rebleeding) (NN time)) (PP-LOC (IN in) (NP (NP (DT the) (NN parent) (NNS strains)) (CC and) (NP (NN CSS))))) (VP (VBD were) (VP (VBN compared) (NP-1 (-NONE- *)) (PP (IN to) (NP (NP (NNS values)) (PP (IN from) (NP (NP (DT the) (NN progeny)) (PP (IN of) (NP (NP (NNS mice)) (SBAR (WHNP-2 (WDT that)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBD were) (VP (VBN crossed) (NP-2 (-NONE- *)) (PP (IN with) (NP (NN B6) (NNS mice))) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB produce) (NP (JJ heterosomic) (NNS mice)) (PP (IN for) (NP (DT the) (NML (NML (NML (NML (NN CSS) (HYPH -) (CD 5)) (, ,) (-LRB- -LRB-) (NML (NN B6xCSS) (HYPH -) (CD 5))) (-RRB- -RRB-) (NN F1)) (CC and) (NML (NML (NML (NN CSS) (HYPH -) (CD 17)) (-LRB- -LRB-) (NML (NN B6xCSS) (HYPH -) (CD 17))) (-RRB- -RRB-) (NN F1))) (NNS strains))) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 5)) (-RRB- -RRB-))))))))))))))))) (. .)) )
( (S (NP-SBJ (NP (DT The) (NN rebleeding) (NNS values)) (PP (IN for) (NP (NML (NML (NN CSS) (HYPH -) (NN 5F1)) (CC and) (NML (NN CSS) (HYPH -) (NN 17F1))) (NNS mice)))) (VP (VBD were) (ADJP-PRD (JJ similar) (PP (IN to) (NP (NP (DT the) (NN B6) (NML-1 (-NONE- *RNR*))) (CONJP (RB rather) (IN than)) (NP (DT the) (NML (NN A) (HYPH /) (NN J)) (NML-1 (-NONE- *RNR*))) (NML-1 (NNS mice))))) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG suggesting) (SBAR (-NONE- *0*) (S (NP-SBJ (DT the) (NML (NN A) (HYPH /) (NN J)) (NN trait)) (VP (VBZ is) (ADJP-PRD (JJ recessive)))))))) (. .)) )
( (S (NP-SBJ (NP (NN Bleeding) (CC and) (NN rebleeding)) (PP (IN in) (NP (NP (DT the) (NN progeny)) (PP (IN of) (NP (NP (DT the) (NN cross)) (, ,) (NP (NP (NML (NN B6) (HYPH -) (NN Chr5A) (HYPH /) (NN J)) (SYM ×) (NML (NN B6) (HYPH -) (NN Chr17A) (HYPH /) (NN J))) (-LRB- -LRB-) (NP (NML (NN CSS) (HYPH -) (CD 5)) (SYM ×) (NML (NN CSS) (HYPH -) (CD 17))))))))) (-RRB- -RRB-) (VP (VBD resulted) (PP (IN in) (NP (NP (DT the) (NN recovery)) (PP (IN of) (NP (DT the) (NML (NN A) (HYPH /) (NN J)) (NN phenotype))) (PP-LOC (IN in) (NP (NP (DT the) (NN progeny)) (PP (IN of) (NP (DT these) (ADJP (JJ double) (JJ heterosomic)) (NNS strains)))))))) (. .)) )
( (S (ADVP (RB Thus)) (, ,) (PP (IN despite) (NP (NP (DT the) (JJ heterosomic) (NNS chromosomes)) (PP (IN of) (NP (CD 5) (CC and) (CD 17))) (PP-LOC (IN in) (NP (NP (DT the) (NN progeny)) (PP (IN of) (NP (DT the) (NML (NML (NN CSS) (HYPH -) (CD 5)) (SYM ×) (NML (NN CSS) (HYPH -) (CD 17))))))))) (, ,) (NP-SBJ (DT the) (NN phenotype)) (VP (VBD was) (ADVP (RB now)) (ADJP-PRD (JJ similar) (PP (IN to) (NP (NN A) (HYPH /) (NN J))))) (. .)) )
( (S (NP-SBJ (DT This)) (VP (VBD suggested) (SBAR (IN that) (S (NP-SBJ (NP (NNS traits)) (PP (IN on) (NP (DT the) (NML (NN A) (HYPH /) (NN J)) (NNS chromosomes)))) (VP (VBD were) (VP (VBG interacting) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB produce) (NP (DT the) (NN phenotype)))))))))) (. .)) )
( (HEADING (NP (NN Figure) (CD 5))) )
( (HEADING (NP (NP (NML (NN Bleeding) (CC and) (NN rebleeding)) (NN time)) (PP (IN in) (NP (DT the) (NN CSS) (NNS backcrosses))) (. .))) )
( (CAPTION (S (NP-SBJ (NP (NP (NN Panel) (NN A)) (: :) (NP (NN Bleeding) (NN Time) (PRN (-LRB- -LRB-) (NP (NNS seconds)) (-RRB- -RRB-)))) (CC and) (NP (NP (NN Panel) (NN B)) (: :) (NP (NN Rebleeding) (NN Time) (PRN (-LRB- -LRB-) (NP (NNS seconds)) (-RRB- -RRB-))))) (VP (VBD were) (VP (VBN tested) (NP-2 (-NONE- *)) (PP-LOC (IN in) (NP (NP (NP (JJ heterosomic) (NNS mice)) (, ,) (NP (NP (NP (-LRB- -LRB-) (NML (NN B6xCSS) (HYPH -) (CD 5)) (-RRB- -RRB-) (NN F1)) (-LRB- -LRB-) (NP (NN 5F1)) (-RRB- -RRB-)) (CC and) (NP (-LRB- -LRB-) (NP (NML (NN B6xCSS) (HYPH -) (CD 17)) (-RRB- -RRB-) (NN F1)) (-LRB- -LRB-) (NP (NN 17F1))))) (-RRB- -RRB-) (CC and) (NP (NP (NP (ADJP (RB doubly) (JJ heterosomic)) (NNS mice)) (PP (IN for) (NP (NNS chromosomes) (NML (CD 5) (CC and) (CD 17))))) (-LRB- -LRB-) (NP (CD 5) (SYM ×) (CD 17))))))) (-RRB- -RRB-) (. .))) )
( (CAPTION (S (NP-SBJ (NNS Bars)) (VP (VBP are) (NP-PRD (NP (DT the) (NML (NN mean) (SYM ±) (NN SEM))) (PP (IN of) (NP (QP (CD 5) (SYM –) (CD 2) (CD 8)) (NNS mice))))) (. .))) )
( (CAPTION (S (S (NP-SBJ-1 (NP (JJ Statistical) (NNS differences)) (PP (IN between) (NP (NP (NN B6) (NNS mice)) (CC and) (NP (DT the) (NN CSS))))) (VP (VBD were) (VP (VBN determined) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (DT a) (NN t) (HYPH -) (NN test)))))) (, ,) (CC and) (S (NP-SBJ-2 (DT a) (NNP Bonferroni) (NN correction)) (VP (VBD was) (VP (VBN made) (NP-2 (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB determine) (NP (NN significance) (NN value) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN P)) (VP (SYM <) (NP (CD 0.01)))) (-RRB- -RRB-))))))))) (. .))) )
( (CAPTION (S (NP-SBJ (NNS Symbols)) (VP (VBP indicate) (NP (NP (DT a) (JJ significant) (NN difference)) (PP (IN between) (NP (NN B6) (NNS values))))) (. .))) )
( (CAPTION (S-FRM (SYM *) (NP-SBJ (NN P)) (VP (SYM <) (NP (CD 0.01))) (. .))) )
( (HEADING (NP (NP (NNS Interactions)) (PP (IN of) (NP (NN CSS))) (PP (IN for) (NP (NML (NN PAI) (HYPH -) (CD 1)) (NML (NN antigen) (CC and) (NN activity)))))) )
( (S (NP-SBJ (NP (NNS Components)) (PP (IN of) (NP (DT the) (NN Plg) (NN system)))) (VP (VBP reside) (PP-LOC (IN on) (NP (NNS chromosomes) (NML (NML (NML (NN CSS) (HYPH -) (CD 5)) (-LRB- -LRB-) (NML (NN PAI) (HYPH -) (CD 1))) (-RRB- -RRB-) (, ,) (NML (NML (NN CSS) (HYPH -) (CD 11)) (-LRB- -LRB-) (NML (NN α2) (HYPH -) (NN antiplasmin))) (-RRB- -RRB-) (, ,) (CC and) (NML (NML (NN CSS) (HYPH -) (CD 17)) (-LRB- -LRB-) (NML (NN Plg))))))) (-RRB- -RRB-) (. .)) )
( (S (SBAR-ADV (IN As) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN reported) (NP-1 (-NONE- *)) (PP (IN in) (NP (NN Table) (CD 2)))))) (, ,) (NP-SBJ (DT the) (NML (NN A) (HYPH /) (NN J)) (NNS mice)) (VP (VBD had) (NP (VBN increased) (NML (NML (NN Plg) (NN antigen)) (, ,) (NML (JJ fibrinolytic) (NN activity)) (, ,) (NML (NN α2) (HYPH -) (NN antiplasmin)) (, ,) (NML (NML (NN PAI) (HYPH -) (CD 1)) (NN activity)) (CC and) (NML (NN fibrinogen)))) (SBAR-TMP (WHADVP-2 (WRB when)) (S (NP-SBJ-3 (-NONE- *PRO*)) (VP (VBN compared) (NP-3 (-NONE- *)) (PP (IN to) (NP (NN B6) (NNS mice))) (ADVP-TMP-2 (-NONE- *T*)))))) (. .)) )
( (S (S (PP-LOC (IN In) (NP (NML (NN CSS) (HYPH -) (CD 17)) (NNS mice))) (, ,) (NP-SBJ (DT the) (NN Plg) (NN antigen)) (VP (VBD was) (RB also) (ADJP-PRD (ADVP (RB significantly) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN P)) (VP (SYM =) (NP (CD 0.015)))) (-RRB- -RRB-))) (JJ increased) (PRN (-LRB- -LRB-) (NP (CD 152) (SYM ±) (CD 6)) (, ,) (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP (CD 12)))) (-RRB- -RRB-))) (SBAR-TMP (WHADVP-1 (WRB when)) (S (NP-SBJ-2 (-NONE- *PRO*)) (VP (VBN compared) (NP-2 (-NONE- *)) (PP (IN to) (NP (DT the) (NN B6) (NNS mice))) (ADVP-TMP-1 (-NONE- *T*))))))) (, ,) (CC but) (S (PP (IN for) (NP (NP (NN CSS) (HYPH -) (CD 5)) (CC and) (NP (NN CSS) (HYPH -) (CD 5) (SYM ×) (CD 17)))) (, ,) (NP-SBJ (DT the) (NN Plg) (NN antigen)) (VP (VBD was) (ADJP-PRD (JJ similar) (PP (IN to) (NP (NP (NNS values)) (PP (IN for) (NP (DT the) (NN B6) (NNS mice)))))))) (. .)) )
( (S (NP-SBJ (JJ Fibrinolytic) (NN activity)) (VP (VBD was) (RB not) (ADJP-PRD (JJ different) (PP (IN in) (NP (DT the) (NML (NML (NN CSS) (HYPH -) (CD 5)) (CC or) (NML (NN CSS) (HYPH -) (CD 17))) (NNS strains)))) (PP (VBN compared) (PP (IN to) (NP (DT the) (NN B6) (NNS mice))))) (. .)) )
( (S (NP-SBJ (NN α2) (HYPH -) (NN antiplasmin)) (VP (VP (VBD was) (ADJP-PRD=1 (ADVP (RB significantly) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN P)) (VP (SYM =) (NP (QP (SYM <) (CD 0.01))))) (-RRB- -RRB-))) (JJ reduced)) (PP-LOC=2 (IN in) (NP (NML (NN CSS) (HYPH -) (CD 5)) (NNS mice) (PRN (-LRB- -LRB-) (NP (NP (QP (CD 142) (SYM ±) (CD 4)) (NNS μg)) (PP (SYM /) (NP (NN mL)))) (, ,) (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP (CD 5)))) (-RRB- -RRB-))))) (, ,) (VP (ADJP-PRD=1 (ADVP (RB significantly) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN P)) (VP (SYM <) (NP (CD 0.05)))) (-RRB- -RRB-))) (JJR higher)) (PP-LOC=2 (IN in) (NP (DT the) (NN CSS) (HYPH -) (CD 11) (PRN (-LRB- -LRB-) (NP (QP (CD 201) (SYM ±) (CD 6))) (, ,) (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP (CD 8)))) (-RRB- -RRB-))))) (, ,) (CC but) (VP (RB not) (ADJP-PRD=1 (JJ different)) (PP-LOC=2 (IN in) (NP (NML (NML (NN CSS) (HYPH -) (CD 17)) (CC or) (NML (NN CSS) (HYPH -) (CD 5) (SYM ×) (CD 17))) (NNS mice))) (PP (VBN compared) (PP (IN to) (NP (DT the) (NN B6) (NNS mice)))))) (. .)) )
( (S (NP-SBJ-1 (NML (NN PAI) (HYPH -) (CD 1)) (NML (NN antigen) (CC and) (NN activity))) (VP (VBD were) (VP (VBN determined) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NP (NP (NP (DT the) (NNS CSS)) (PP (IN with) (NP (VBN increased) (NN rebleeding) (NNS times)))) (, ,) (NP (NP (NN CSS) (HYPH -) (CD 5)) (, ,) (NP (NN CSS) (HYPH -) (CD 11)) (, ,) (CC and) (NP (NN CSS) (HYPH -) (CD 17) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 6)) (-RRB- -RRB-))))) (, ,) (NP (NP (DT the) (JJ heterosomic)) (, ,) (NP (NP (NN CSS) (HYPH -) (NN 5F1)) (, ,) (NP (NN CSS) (HYPH -) (NN 17F1)))) (, ,) (CC and) (NP (NP (JJ double) (JJ hetersomic)) (, ,) (NP (NN CSS) (HYPH -) (CD 5) (SYM ×) (CD 17))))))) (. .)) )
( (S (NP-SBJ (NP (NN CSS) (HYPH -) (CD 5)) (, ,) (NP (NN CSS) (HYPH -) (CD 17)) (, ,) (NP (NN CSS) (HYPH -) (NN 5F1)) (, ,) (CC and) (NP (NN CSS) (HYPH -) (NN 17F1))) (ADVP (RB generally)) (VP (VBD had) (NP (VBN reduced) (NML (NN PAI) (HYPH -) (CD 1)) (NN antigen)) (SBAR-TMP (WHADVP-1 (WRB when)) (S (NP-SBJ-2 (-NONE- *PRO*)) (VP (VBN compared) (NP-2 (-NONE- *)) (PP (IN to) (NP (NN B6) (NNS mice))) (ADVP-TMP-1 (-NONE- *T*)))))) (. .)) )
( (S (NP-SBJ (DT The) (VBN reduced) (NML (NN PAI) (HYPH -) (CD 1)) (NN antigen)) (VP (VBD was) (NP-PRD (DT a) (JJ dominant) (NN trait)) (PP-PRP (IN due) (IN to) (NP (DT the) (NN fact) (SBAR (IN that) (S (NP-SBJ (DT the) (NNS values)) (VP (VBD were) (ADJP-PRD (JJ similar) (PP (IN in) (NP (DT the) (ADJP (JJ homosomic) (CC and) (JJ heterosomic)) (NML (NML (NN CSS) (HYPH -) (CD 5)) (CC and) (NML (NN CSS) (HYPH -) (CD 17)))))))))))) (. .)) )
( (S (NP-SBJ (DT The) (NML (NML (NN CSS) (HYPH -) (CD 5)) (SYM ×) (NML (NN CSS) (HYPH -) (CD 17))) (ADJP (JJ double) (JJ heterosomic)) (NNS strains)) (VP (VBD had) (NP (NP (NNS values)) (ADJP (JJ similar) (PP (IN to) (NP (DT the) (NML (NML (NN B6)) (CC and) (NML (NN A) (HYPH /) (NN J))) (NN parent) (NNS strains)))))) (. .)) )
( (S (S (NP-SBJ-2 (NML (NN PAI) (HYPH -) (CD 1)) (NN activity)) (VP (VBD was) (ADVP (RB significantly)) (VP (VBN reduced) (NP-2 (-NONE- *)) (PP-LOC (IN in) (NP (DT the) (NML (NML (NN CSS) (HYPH -) (CD 5)) (CC and) (NML (NN CSS) (HYPH -) (NN 17F1))) (NNS mice)))))) (, ,) (CC but) (S (ADVP-TMP (RB again)) (PP-LOC (IN in) (NP (DT the) (NML (NML (NN CSS) (HYPH -) (CD 5)) (SYM ×) (NML (NN CSS) (HYPH -) (CD 17))) (NN strain))) (NP-SBJ-1 (NP (DT the) (NN value)) (PP (IN for) (NP (NML (NN PAI) (HYPH -) (CD 1)) (NN activity)))) (VP (VBD was) (VP (VBN restored) (NP-1 (-NONE- *)) (PP (IN to) (NP (NP (DT the) (NN value)) (PP (IN of) (NP (DT the) (NML (NML (NN B6)) (CC and) (NML (NN A) (HYPH /) (NN J))) (NN parent) (NNS strains)))))))) (. .)) )
( (S (NP-SBJ (NP (DT The) (NML (NML (NN PAI) (HYPH -) (CD 1)) (NN antigen) (PRN (-LRB- -LRB-) (NP (NP (QP (CD 5.4) (QP-1 (-NONE- *ICH*))) (NNS ng)) (PP (SYM /) (NP (NN mL))) (QP-1 (SYM ±) (CD 0.5))) (, ,) (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP (CD 7)))) (-RRB- -RRB-))) (CC and) (NML (NN activity) (PRN (-LRB- -LRB-) (NP (NP (QP (CD 170) (QP-2 (-NONE- *ICH*))) (NNS U)) (PP (SYM /) (NP (NN mL))) (QP-2 (SYM ±) (CD 20))) (, ,) (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP (CD 6)))) (-RRB- -RRB-)))) (PP-LOC (IN in) (NP (DT the) (NML (NN CSS) (HYPH -) (CD 11)) (NNS mice)))) (VP (VBD was) (RB not) (ADJP-PRD (ADJP (JJ different)) (PP (IN than) (PP (IN for) (NP (NN B6) (NNS mice)))))) (. .)) )
( (HEADING (NP (NN Figure) (CD 6))) )
( (HEADING (NP (NP (NN PAI) (HYPH -) (CD 1)) (PP (IN in) (NP (DT the) (NN CSS) (NNS backcrosses))) (. .))) )
( (CAPTION (S (NP-SBJ (NP (NP (NN Panel) (NN A)) (: :) (NP (NN Plasma) (NML (NN PAI) (HYPH -) (CD 1)) (NN antigen) (PRN (-LRB- -LRB-) (NP (NP (NNS ng)) (PP (SYM /) (NP (NN mL)))) (-RRB- -RRB-)))) (CC and) (NP (NP (NN Panel) (NN B)) (: :) (NP (NN Plasma) (NML (NN PAI) (HYPH -) (CD 1)) (NN activity) (PRN (-LRB- -LRB-) (NP (NP (NNS U)) (PP (SYM /) (NP (NN mL)))) (-RRB- -RRB-))))) (VP (VBD were) (VP (VBN tested) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NP (NP (JJ heterosomic) (NNS mice)) (, ,) (NP (-LRB- -LRB-) (NP (NP (NML (NN B6xCSS) (HYPH -) (CD 5)) (-RRB- -RRB-) (NN F1)) (-LRB- -LRB-) (NP (NN 5F1))) (-RRB- -RRB-) (CC and) (-LRB- -LRB-) (NP (NP (NML (NN B6xCSS) (HYPH -) (CD 17)) (-RRB- -RRB-) (NN F1)) (-LRB- -LRB-) (NP (NN 17F1))))) (-RRB- -RRB-) (CC and) (NP (NP (NP (ADJP (RB doubly) (JJ heterosomic)) (NNS mice)) (PP (IN for) (NP (NNS chromosomes) (NML (CD 5) (CC and) (CD 17))))) (-LRB- -LRB-) (NP (CD 5) (SYM ×) (CD 17))))))) (-RRB- -RRB-) (. .))) )
( (CAPTION (S (NP-SBJ (NNS Bars)) (VP (VBP are) (NP-PRD (NP (DT the) (NML (NN mean) (SYM ±) (NN SEM))) (PP (IN of) (NP (QP (CD 5) (SYM –) (CD 18)) (NNS mice))))) (. .))) )
( (CAPTION (S (S (NP-SBJ-1 (NP (JJ Statistical) (NNS differences)) (PP (IN between) (NP (NN B6) (NNS mice) (CC and) (NN CSS)))) (VP (VBD were) (VP (VBN determined) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (DT a) (NN t) (HYPH -) (NN test)))))) (, ,) (CC and) (S (NP-SBJ-2 (DT a) (NNP Bonferroni) (NN correction)) (VP (VBD was) (VP (VBN made) (NP-2 (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB determine) (NP (NN significance) (NN value)) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN P)) (VP (SYM <) (NP (CD 0.01)))) (-RRB- -RRB-)))))))) (. .))) )
( (CAPTION (S (NP-SBJ (NNS Symbols)) (VP (VBP indicate) (NP (NP (DT a) (JJ significant) (NN difference)) (PP (IN between) (NP (NN B6) (NNS values))))) (. .))) )
( (CAPTION (S-FRM (NP-SBJ (SYM *) (NN P)) (VP (SYM <) (NP (CD 0.01))) (. .))) )
( (HEADING (NP (NP (NNS Interactions)) (PP (IN of) (NP (NN CSS))) (PP (IN for) (NP (NML (JJ arterial) (NN thrombus)) (NN formation))))) )
( (S (S (NP-SBJ (DT The) (NML (NN tail) (NN bleeding)) (NN assay)) (VP (VP (VBD was) (ADJP-PRD (JJ rapid))) (CC and) (VP (VBD facilitated) (NP (NP (DT the) (NN screening)) (PP (IN of) (NP (DT the) (CD 21) (NN CSS) (NNS strains))))))) (, ,) (CC and) (S (ADVP-TMP (RB subsequently)) (NP-SBJ-1 (DT the) (VBN identified) (NNS strains)) (VP (VBD were) (VP (VBN tested) (NP-1 (-NONE- *)) (PP (IN for) (NP (JJ arterial) (NN occlusion))) (PP-TMP (IN after) (NP (DT the) (NN FeCl3) (NN injury))) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 7)) (-RRB- -RRB-))))) (. .)) )
( (S (S (NP-SBJ (DT The) (NML (NML (NN CSS) (HYPH -) (CD 5)) (CC and) (NML (NN CSS) (HYPH -) (CD 17)))) (VP (VBD had) (NP (NP (NN occlusion) (NNS times)) (ADJP (JJ similar) (PP (IN to) (NP (DT the) (NN B6) (NNS mice))))))) (, ,) (CC but) (S (NP-SBJ (DT the) (ADJP (RB doubly) (JJ heterosomic)) (NML (NML (NN CSS) (HYPH -) (CD 5)) (SYM ×) (NML (NN CSS) (HYPH -) (CD 17))) (NN progeny)) (VP (VBD had) (NP (NP (NN occlusion) (NNS times)) (ADJP (ADJP (JJR higher)) (PP (IN than) (NP (CC either) (NP (DT the) (NN B6) (NNS mice)) (CC or) (NP (NP (DT the) (JJ heterosomic) (NML (NML (NN CSS) (HYPH -) (NN 5F1)) (CC and) (NML (NN CSS) (HYPH -) (NN 17F1))) (NML-1 (-NONE- *RNR*))) (CC or) (NP (DT the) (NML (NN A) (HYPH /) (NN J)) (NML-1 (-NONE- *RNR*))) (NML-1 (NNS strains))))))))) (. .)) )
( (S (S (PP-LOC (IN In) (NP (ADJP (JJ double) (JJ heterosomic)) (NML (NML (NN CSS) (HYPH -) (CD 5)) (SYM ×) (NML (NN CSS) (HYPH -) (CD 17))) (NNS mice))) (, ,) (NP-SBJ (NP (RB only) (NML (CD one) (CC or) (CD three)) (NNS mice)) (VP (VBN tested) (NP (-NONE- *)))) (VP (VBD had) (VP (VBN occluded) (PP-TMP (IN by) (NP (CD 30) (NNS min)))))) (: ;) (S (NP-SBJ (DT the) (JJ other) (CD two) (NNS mice)) (VP (VBD did) (RB not) (VP (VB occlude) (PP-TMP (IN by) (NP (CD 30) (NNS min)))))) (. .)) )
( (S (SBAR-ADV (IN While) (S (NP-SBJ-1 (NP (RB only) (DT a) (JJ small) (NN number)) (PP (IN of) (NP (NN CSS) (NNS mice)))) (VP (VBP have) (VP (VBN been) (VP (VBN tested) (NP-1 (-NONE- *)) (PP (IN for) (NP (DT the) (JJ arterial) (NN occlusion)))))))) (, ,) (NP-SBJ (DT the) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (NP-SBJ (NP (NN interaction)) (PP (IN of) (NP (NP (DT the) (NNS genes)) (PP-LOC (IN on) (NP (NN chromosome) (NML (CD 5) (CC and) (CD 17))))))) (ADVP (RB also)) (VP (VBZ determines) (NP (NML (JJ arterial) (NN occlusion)) (NN time)))))) (. .)) )
( (HEADING (NP (NN Figure) (CD 7))) )
( (HEADING (NP (NP (NML (JJ Arterial) (NN occlusion)) (NN time)) (PP-LOC (IN in) (NP (DT the) (NN CSS) (NNS backcrosses))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NN Occlusion) (NN time)) (VP (VBD was) (VP (VBN determined) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NP (NP (JJ heterosomic) (NNS mice)) (, ,) (-LRB- -LRB-) (NP (NP (NP (NML (NN B6xCSS) (HYPH -) (CD 5)) (-RRB- -RRB-) (NN F1)) (-LRB- -LRB-) (NP (NN 5F1))) (-RRB- -RRB-) (CC and) (-LRB- -LRB-) (NP (NP (NML (NN B6xCSS) (HYPH -) (CD 17)) (-RRB- -RRB-) (NN F1)) (-LRB- -LRB-) (NP (NN 17F1))))) (-RRB- -RRB-) (, ,) (CC and) (NP (NP (NP (ADJP (RB doubly) (JJ heterosomic)) (NNS mice)) (PP (IN for) (NP (NNS chromosomes) (NML (CD 5) (CC and) (CD 17))))) (-LRB- -LRB-) (NP (CD 5) (SYM ×) (CD 17))))))) (-RRB- -RRB-) (. .))) )
( (CAPTION (S (NP-SBJ (NNS Bars)) (VP (VBP are) (NP-PRD (NP (DT the) (NML (NN mean) (SYM ±) (NN SEM))) (PP (IN of) (NP (QP (CD 5) (SYM –) (CD 18)) (NNS mice))))) (. .))) )
( (CAPTION (S (S (NP-SBJ-1 (NP (JJ Statistical) (NNS differences)) (PP (IN between) (NP (NP (NN B6) (NNS mice)) (CC and) (NP (NN CSS))))) (VP (VBD were) (VP (VBN determined) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (DT a) (NN t) (HYPH -) (NN test)))))) (, ,) (CC and) (S (NP-SBJ-2 (DT a) (NNP Bonferroni) (NN correction)) (VP (VBD was) (VP (VBN made) (NP-2 (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB determine) (NP (NN significance) (NN value) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN P)) (VP (SYM <) (NP (CD 0.02)))) (-RRB- -RRB-))))))))) (. .))) )
( (CAPTION (S (NP-SBJ (NNS Symbols)) (VP (VBP indicate) (NP (NP (DT a) (JJ significant) (NN difference)) (PP (IN between) (NP (NN B6) (NNS values))))) (. .))) )
( (CAPTION (S-FRM (NP-SBJ (SYM *) (NN P)) (VP (SYM <) (NP (CD 0.0001))) (. .))) )
( (HEADING (NP (NN Discussion))) )
( (S (PP (IN In) (NP (DT this) (NN study))) (, ,) (NP-SBJ-1 (JJ thrombotic) (NN risk)) (VP (VBD was) (ADVP-MNR (RB systematically)) (VP (VBN assessed) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NP (NP (CD two) (JJ inbred) (NNS strains)) (PP (IN of) (NP (NNS mice)))) (SBAR (WHNP-2 (WDT that)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBP have) (NP (NP (VBN marked) (NNS differences)) (PP (IN in) (NP (NP (NN susceptibility)) (PP (IN to) (NP (NP (ADJP (NN diet) (HYPH -) (VBN induced)) (NN obesity)) (, ,) (NP (ADJP (NN diet) (HYPH -) (VBN induced)) (NN atherosclerosis)) (, ,) (CC and) (NP (ADJP (NN ligation) (HYPH -) (VBN induced)) (NML (NML (JJ neointimal) (NN hyperplasia)) (CC and) (NML (NN vessel) (NN remodeling)))))))))))))))) (. .)) )
( (S (NP-SBJ-1 (NP (NML (JJ Arterial) (NN occlusion)) (NN time)) (, ,) (NP (NML (NN tail) (NML (NN bleeding) (CC and) (NN rebleeding))) (NN time))) (VP (VBD were) (VP (VBN evaluated) (NP-1 (-NONE- *)) (PP (IN as) (NP (NP (JJ potential) (NNS predictors)) (PP (IN of) (NP (JJ thrombotic) (NN response))))))) (. .)) )
( (S (NP-SBJ-1 (NP (NNS Assessments)) (PP (IN of) (NP (DT the) (CD two) (JJ inbred) (NNS strains)))) (VP (VBD were) (VP (VBN compared) (NP-1 (-NONE- *)) (PP (IN to) (NP (NP (NNS values)) (PP (PP (IN from) (NP (NP (ADJP (NN gene) (VBN targeted)) (NNS mice)) (PP (IN of) (NP (DT the) (NN Plg) (NN network))) (PP (IN with) (NP (VBN altered) (JJ fibrinolytic) (NNS responses))))) (, ,) (CONJP (RB as) (RB well) (IN as)) (PP-LOC (IN in) (NP (NP (ADJP (NN leptin) (JJ deficient)) (NNS mice)) (PP (IN with) (NP (DT a) (VBN reduced) (NN platelet) (NN function)))))))))) (. .)) )
( (S (S (NP-SBJ-1 (JJ Marked) (NNS differences)) (VP (VBD were) (VP (VBN found) (NP-1 (-NONE- *)) (PP (IN in) (NP (DT the) (JJ thrombotic) (NN response))) (PP-LOC (IN among) (NP (NP (DT the) (CD two) (JJ inbred) (NNS strains)) (, ,) (NP (NP (NN B6)) (CC and) (NP (NN A) (HYPH /) (NN J)))))))) (, ,) (CC and) (S (NP-SBJ-2 (DT the) (VBN observed) (NNS differences)) (VP (VBD were) (RB not) (VP (VBN correlated) (NP-2 (-NONE- *)) (PP (IN with) (NP (NP (NN change)) (PP (IN in) (NP (NP (NN coagulation)) (CC or) (NP (NN platelet) (NN function))))))))) (. .)) )
( (S (S-NOM-SBJ (NP-SBJ (-NONE- *PRO*)) (VP (VBG Screening) (NP (DT the) (NN CSS)))) (VP (VBD identified) (NP (NP (CD three) (NNS chromosomes)) (SBAR (WHNP-2 (WDT that)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBD harbored) (NP (NP (NNS genes)) (SBAR (WHNP-1 (WDT which)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBD contributed) (PP (IN to) (NP (NP (DT the) (NML (NN A) (HYPH /) (NN J)) (NN phenotype)) (PP (IN of) (NP (VBN increased) (NN rebleeding) (NN time)))))))))))))) (. .)) )
( (S (NP-SBJ-1 (NP (NNS Mice)) (ADJP (ADJP (JJ homosomic) (PP (IN for) (NP (DT these) (NNS chromosomes)))) (CC or) (ADJP (RB doubly) (JJ heterosomic) (PP (IN for) (NP (NP (NP (CD two)) (PP (IN of) (NP (DT the) (NNS chromosomes)))) (, ,) (NP (CD 5) (CC and) (CD 17))))))) (, ,) (VP (VBD were) (VP (VBN required) (NP-1 (-NONE- *)) (S-PRP (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO to) (VP (VB express) (NP (NP (DT the) (NML (NN A) (HYPH /) (NN J)) (NN phenotype)) (, ,) (NP (VBN elevated) (NN rebleeding) (NN time)))))))) (. .)) )
( (S (NP-SBJ-1 (NML (NN PAI) (HYPH -) (CD 1)) (NML (NN antigen) (CC and) (NN activity))) (VP (VBD were) (VP (VBN decreased) (NP-1 (-NONE- *)) (PP-LOC (PP (IN in) (NP (CC both) (NP (NP (NN CSS) (HYPH -) (CD 5)) (CC and) (NP (NN CSS) (HYPH -) (CD 17))) (CC and) (NP (NP (DT the) (JJ heterosomic) (NNS mice)) (, ,) (NP (NP (NN CSS) (HYPH -) (NN 5F1)) (CC and) (NP (NN CSS) (HYPH -) (NN 17F1)))))) (, ,) (CONJP (CC but) (RB not)) (PP-LOC (IN in) (NP (DT the) (NML (NN CSS) (HYPH -) (CD 11)) (NN strain)))))) (. .)) )
( (S (NP-SBJ-1 (NNS Values)) (VP (VBD were) (VP (VBN restored) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (DT the) (RB doubly) (JJ heterosomic))) (PP (IN for) (NP (NP (NP (CD two)) (PP (IN of) (NP (NNS chromosomes)))) (, ,) (NP (CD 5) (CC and) (CD 17)))))) (. .)) )
( (S (NP-SBJ (NML (JJ Arterial) (NN occlusion)) (NN time)) (VP (VP (VP (VBD was) (ADJP-PRD=2 (JJ similar) (PP (IN to) (NP (NN B6)))) (PP-LOC (IN in) (NP (DT the) (NML (NML (NN CSS) (HYPH -) (CD 5)) (CC and) (NML (NN CSS) (HYPH -) (CD 17))) (JJ homozygous) (NNS strains)))) (, ,) (CC but) (VP (VBD increased) (PP-LOC (IN in) (NP (RB doubly) (JJ heterosomic))))) (PP (IN for) (NP (NP (NP (CD two)) (PP (IN of) (NP (NNS chromosomes)))) (, ,) (NP (CD 5) (CC and) (CD 17))))) (. .)) )
( (S (NP-SBJ-1 (NP (DT The) (ADJP (NN FeCl3) (HYPH -) (VBN induced)) (NN model)) (PP (IN of) (NP (NP (JJ vascular) (NN injury)) (CC and) (NP (NN thrombosis)))) (PP-LOC (IN in) (NP (NNS mice)))) (VP (VBZ is) (ADVP-TMP (RB now)) (ADVP-MNR (RB widely)) (VP (VBN used) (NP-1 (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB evaluate) (NP (ADJP (JJ genetic) (CC and) (JJ pharmacological)) (NNS interventions))))) (PRN (-LRB- [) (NP (CD 24)) (-RRB- ])))) (. .)) )
( (S (NP-SBJ (DT The) (CD two) (JJ inbred) (NNS strains)) (VP (VBD had) (NP (NP (JJ marked) (NNS differences)) (PP (IN in) (NP (NP (DT the) (NN time)) (PP (IN for) (NP (NP (NN occlusion)) (PP (IN of) (NP (DT the) (JJ carotid) (NN artery))) (PP-TMP (IN after) (NP (NN FeCl3) (NN injury))))))))) (. .)) )
( (S (PP-TMP (IN After) (NP (NN FeCl3) (NN treatment))) (, ,) (NP-SBJ-1 (NN thrombus) (NML (NN formation) (CC and) (NN occlusion))) (VP (VBD was) (ADVP (RB remarkably)) (VP (VBN shortened) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (DT the) (NML (NN A) (HYPH /) (NN J)) (NNS mice))) (PP (VBN compared) (PP (IN to) (NP (DT the) (NN B6) (NNS mice)))))) (. .)) )
( (S (NP-SBJ-1 (DT These) (NNS results)) (VP (VBP have) (RB not) (ADVP-TMP (RB previously)) (VP (VBN been) (VP (VBN reported) (NP-1 (-NONE- *))))) (. .)) )
( (S (NP-SBJ (NP (DT A) (JJ recent) (NN study) (PRN (-LRB- [) (NP (CD 25)) (-RRB- ]))) (PP (IN of) (NP (JJ sheer) (NN stress))) (PP-LOC (IN in) (NP (NNS rats)))) (, ,) (VP (VBD found) (SBAR (IN that) (S (NP-SBJ (NP (DT the) (NN magnitude)) (PP (IN of) (NP (NP (NNS changes)) (PP (IN in) (NP (JJ sheer) (NN stress))))) (PP (IN with) (NP (VBN increased) (NN blood) (NN flow)))) (VP (VBD varied) (PP (IN with) (NP (DT the) (JJ different) (NNS strains))))))) (. .)) )
( (S (NP-SBJ (NP (JJ Further) (NN investigation)) (, ,) (PP (IN beyond) (NP (NP (DT the) (NN scope)) (PP (IN of) (NP (DT this) (NN study)))))) (VP (MD would) (VP (VB be) (ADJP-PRD (JJ necessary)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB determine) (NP (NP (DT the) (NN contribution)) (PP (IN in) (NP (NP (NP (DT the) (NNS differences)) (PP (IN in) (NP (NN size)))) (CC and) (NP (NP (JJ sheer) (NN stress)) (PP (IN of) (NP (DT the) (NNS carotids)))))) (PP (IN to) (NP (NP (JJ arterial) (NN occlusion) (NNS rates)) (PP-LOC (IN in) (NP (DT the) (NML (NML (NN B6)) (CC and) (NML (NN A) (HYPH /) (NN J))) (NNS mice))))))))))) (. .)) )
( (S (PP (IN In) (NP (JJ preliminary) (NNS studies))) (, ,) (NP-SBJ (PRP we)) (VP (VBP have) (VP (VBN noted) (NP (NP (NNS differences)) (PP (IN in) (NP (NP (DT the) (NN composition)) (PP (IN of) (NP (DT the) (NN thrombus)))))) (PP-LOC (IN in) (NP (NML (NML (NN B6)) (CC and) (NML (NN A) (HYPH /) (NN J))) (NNS mice))))) (. .)) )
( (S (S (NP-SBJ (NP (DT The) (NN pattern)) (PP (IN of) (NP (NML (NN blood) (NN flow)) (NN cessation))) (PP (IN for) (NP (DT the) (CD two) (JJ inbred) (NNS strains)))) (VP (VBD was) (ADJP-PRD (JJ different) (PP (IN than) (PP (IN for) (NP (NP (DT the) (NN Lepob) (NNS mice) (PRN (-LRB- [) (NP (CD 26)) (-RRB- ]))) (PP (IN with) (NP (JJ impaired) (NN platelet) (NN function))))))))) (, ,) (CC and) (S (NP-SBJ (NN coagulation) (NN time)) (VP (VBD was) (ADJP-PRD (JJ similar)) (PP-LOC (IN in) (NP (DT the) (CD two) (NNS strains))))) (. .)) )
( (S (PP-LOC (IN In) (NP (NP (DT the) (NNS mice)) (PP (IN with) (NP (NP (NNS deficiencies)) (PP (IN of) (NP (DT the) (NN Plg) (NN network))))) (PRN (-LRB- [) (NP (CD 27)) (-RRB- ])))) (, ,) (NP-SBJ-1 (NML (NN thrombus) (NN formation)) (NN time)) (VP (VBD was) (VP (VP (VP (VBN reduced) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (DT the) (NML (NN Plg) (SYM -) (HYPH /) (SYM -)) (NNS mice)))) (, ,) (CC but) (VP (VBD increased) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (DT the) (NML (NN PAI) (SYM -) (HYPH /) (SYM -)) (NNS mice))))) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG suggesting) (SBAR (IN that) (S (NP-SBJ (NP (NP (NNS alterations)) (PP (IN in) (NP (NN plasmin) (NN activity)))) (SBAR (WHNP-2 (WDT that)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBP affect) (NP (NP (DT the) (NN rate)) (PP (IN of) (NP (NN clot) (NN lysis)))))))) (, ,) (VP (MD can) (VP (VB modulate) (NP (NP (DT the) (NNS events)) (VP (VBG leading) (PP (IN to) (NP (NML (JJ occlusive) (NN thrombus)) (NN formation))))))))))))) (. .)) )
( (S (NP-SBJ-1 (DT The) (NML (NN tail) (HYPH -) (NN bleeding)) (NN assay)) (VP (VBZ has) (VP (VBN been) (VP (VBN used) (NP-1 (-NONE- *)) (ADVP (RB extensively)) (PP-LOC (IN in) (NP (NNS mice))) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB assess) (NP (NP (DT the) (NN impact)) (PP (IN of) (NP (NP (NP (NNS deficiencies)) (CC and) (NP (RB over) (NN expression))) (PP (IN of) (NP (NML (NN platelet) (CC and) (NN coagulation)) (NN proteins))) (PP-LOC (IN in) (NP (NNS mice)))))))))))) (. .)) )
( (S (NP-SBJ (NP (NNP Sweeny)) (ADVP-ETC (FW et) (FW al)) (PRN (-LRB- [) (NP (CD 28)) (-RRB- ]))) (VP (VP (VBD screened) (NP (NP (CD 25) (NNS strains)) (PP (IN of) (NP (NNS mice))))) (CC and) (VP (VBN found) (S (NP-SBJ (RB only) (DT the) (NML (NN RIIS) (HYPH /) (NN J)) (NNS mice)) (VP (TO to) (VP (VB have) (NP (NP (VBN increased) (NN bleeding) (NN time)) (PP (IN due) (IN to) (NP (VBN reduced) (NML (NNP von) (NNP Willebrand)) (NN antigen))))))))) (. .)) )
( (S (NP-SBJ (NP (NNP Broze)) (ADVP-ETC (FW et) (FW al)) (PRN (-LRB- [) (NP (CD 29)) (-RRB- ]))) (VP (VP (VBN evaluated) (NP (NP (NNS mice)) (PP (IN with) (NP (NP (NN gene) (NNS deletions)) (PP (IN of) (NP (DT the) (NN coagulation) (NN pathway))))))) (CC and) (VP (VBD found) (SBAR (IN that) (S (SBAR-TMP (IN while) (S (NP-SBJ-1 (NN bleeding) (NN time)) (VP (VBD was) (RB not) (VP (VBN increased) (NP-1 (-NONE- *)))))) (, ,) (NP-SBJ (NN rebleeding)) (VP (VBD persisted) (PP (IN despite) (NP (NP (NN electrocautery)) (PP (IN of) (NP (DT the) (NN tail))))) (PP-LOC (IN in) (NP (ADJP (NP (NN FVIII) (CC and) (NN FIX)) (JJ deficient)) (NNS mice)))))))) (. .)) )
( (S (NP-SBJ (DT This) (NN observation)) (VP (VBD raised) (NP (DT the) (NN possibility) (SBAR (IN that) (S (NP-SBJ (NN rebleeding) (NN time)) (VP (MD may) (VP (VB be) (NP-PRD (NP (DT a) (JJ sensitive) (NN reporter)) (PP (IN of) (NP (NP (JJ genetic) (NNS influences)) (PP (IN on) (NP (NN thrombus) (NML (NN formation) (CC and) (NN stability))))))))))))) (. .)) )
( (S (NP-SBJ (NP (NNS Mice)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBP are) (ADJP-PRD (JJ deficient) (PP (IN in) (NP (NP (NNS factors)) (VP (VBN required) (NP (-NONE- *)) (PP-PRP (IN for) (NP (NP (JJ normal) (NN platelet) (NN function)) (, ,) (NP (NN platelet) (NN glycoprotein) (NN Ib) (PRN (-LRB- [) (NP (CD 30)) (-RRB- ]))) (, ,) (CC and) (NP (ADJP (NN protease) (HYPH -) (VBN activated)) (NN receptor) (HYPH -) (CD 4)))) (, ,) (PRN (-LRB- [) (NP (CD 31)) (-RRB- ])))))))))) (VP (VBP have) (VP (VBN increased) (NP (NML (NN tail) (NN bleeding)) (NN time)))) (. .)) )
( (S (S (NP-SBJ (NP (DT The) (NN leptin) (NN deficiency)) (PP (IN with) (NP (VBN reduced) (NN platelet) (NN aggregation)))) (ADVP (RB clearly)) (VP (VBZ shows) (NP (NP (DT a) (JJ marked) (NN increase)) (PP (IN in) (NP (NN bleeding) (NN time)))))) (CC and) (S (NP-SBJ (NP (DT the) (VBN increased) (NN bleeding) (NN time)) (PP-LOC (IN in) (NP (NML (NML (NN Plg) (SYM -) (HYPH /) (SYM -)) (CC and) (NML (NN uPA) (SYM -) (HYPH /) (SYM -))) (NNS mice)))) (VP (VBZ suggests) (SBAR (IN that) (S (NP-SBJ (NN Plg) (CC and) (NN uPA)) (VP (MD may) (VP (VB exert) (NP (NP (DT an) (NN influence)) (PP (IN on) (NP (NN platelet) (NN response)))) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB promote) (NP (JJ normal) (NN thrombus) (NN formation))))))))))) (. .)) )
( (S (ADVP (RB Overall)) (, ,) (NP-SBJ (NP (NP (DT the) (JJ marked) (NN increase)) (PP (IN in) (NP (NN rebleeding) (NNS times)))) (VP (VBN observed) (NP (-NONE- *)) (PP-LOC (IN in) (NP (JJ certain) (NN mouse) (NNS strains))))) (VP (VBZ suggests) (SBAR (-NONE- *0*) (S (NP-SBJ (NP (JJ genetic) (NNS factors)) (ADJP (JJ other) (PP (IN than) (NP (NN coagulation))))) (VP (MD may) (VP (VB play) (NP (DT a) (NN role)) (PP (IN in) (NP (NP (DT the) (NN stability)) (PP (IN of) (NP (DT a) (NN thrombus)))))))))) (. .)) )
( (S (S (PP (IN In) (NP (DT the) (NML (NN tail) (NN bleeding)) (NN assay))) (, ,) (NP-SBJ (NML (NN A) (HYPH /) (NN J)) (NNS mice)) (VP (VBD did) (RB not) (VP (VB have) (NP (NP (NNS changes)) (PP (IN in) (NP (NN bleeding) (NN time))))))) (, ,) (CC but) (S (NP-SBJ (NN rebleeding) (NN time)) (VP (VBD was) (ADJP-PRD (JJR higher)) (PP (VBN compared) (PP (IN to) (NP (NN B6) (NNS mice)))))) (. .)) )
( (S (S (PP (IN In) (NP (PRP$ our) (NN study))) (, ,) (NP-SBJ (NML (NN Plg) (SYM -) (HYPH /) (SYM -)) (NNS mice)) (VP (VBD had) (NP (VBN increased) (NN bleeding) (NN time)))) (, ,) (S (NP-SBJ (NML (NN PAI) (HYPH -) (CD 1)) (SYM -) (HYPH /) (SYM -)) (VP (VBD had) (NP (VBN decreased) (NN rebleeding) (NN time)))) (, ,) (CC and) (S (NP-SBJ (NML (NN uPA) (SYM -) (HYPH /) (SYM -)) (NNS mice)) (VP (VBD had) (NP (NP (DT an) (VBN increased) (NN bleeding) (NN time)) (ADJP (JJ similar) (PP (IN to) (NP (DT the) (NML (NN Plg) (SYM -) (HYPH /) (SYM -)) (NNS mice))))) (CIT (-LRB- -LRB-) (NNP J.) (NNP Hoover) (HYPH -) (NNP Plow) (, ,) (NNP A.) (NNP Shchurin) (, ,) (CC and) (NNP E.) (NNP Hart) (, ,) (JJ unpublished) (NNS results) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ-1 (VBN Increased) (NML (NN bleeding) (CC or) (NN rebleeding)) (NNS times)) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN reported) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NP (DT any)) (PP (IN of) (NP (DT the) (ADJP (NP (NN Plg) (NN network)) (VBN targeted)) (NNS mice)))))))) (. .)) )
( (S (S (S (NP-SBJ (NP (NNP Matsuno)) (ADVP-ETC (FW et) (FW al)) (PRN (-LRB- [) (NP (CD 32)) (-RRB- ]))) (VP (VBD reported) (NP (NP (DT no) (NN difference)) (PP (IN in) (NP (NN bleeding) (NN time))) (PP (IN for) (NP (NP (NML (NML (NN tPA) (SYM -) (HYPH /) (SYM -)) (, ,) (NML (NN uPA) (SYM -) (HYPH /) (SYM -)) (, ,) (NML (NML (NN PAI) (HYPH -) (CD 1)) (SYM -) (HYPH /) (SYM -))) (NNS mice)) (PP (VBN compared) (PP (IN to) (NP (NN WT) (NNS mice))))))))) (, ,) (CC and) (S (NP-SBJ (DT the) (NN assay)) (VP (VBD was) (ADJP-PRD (JJ similar))))) (, ,) (CC but) (S (S (NP-SBJ=2 (DT the) (NML (NN tail) (NN clip)) (NN segment)) (VP (VBD was) (ADJP-PRD=1 (RB considerably) (JJR shorter)))) (CC and) (S (NP-SBJ=2 (NN bleeding) (NNS times)) (ADJP-PRD=1 (JJ reduced)) (PP (VBN compared) (PP (IN to) (NP (NP (DT the) (NNS times)) (VP (VBN reported) (NP (-NONE- *)) (PP (IN in) (NP (PRP$ our) (NN study))))))))) (. .)) )
( (S (NP-SBJ-1 (NN Bleeding) (NN time)) (VP (VBZ has) (RB not) (VP (VBN been) (ADVP-TMP (RB previously)) (VP (VBN reported) (NP-1 (-NONE- *)) (PP (IN for) (NP (NML (NN Plg) (SYM -) (HYPH /) (SYM -)) (NNS mice)))))) (. .)) )
( (S (NP-SBJ (PRP We)) (VP (VBP have) (VP (VBN found) (NP (NP (JJ similar) (NNS values)) (PP (IN for) (NP (NP (NML (NN Plg) (SYM -) (HYPH /) (SYM -)) (NNS mice)) (PP-LOC (IN in) (NP (DT a) (NML (NML (NML (CD 50) (NN %)) (NN B6)) (: :) (NML (NML (CD 50) (NN %)) (CD 129))) (NN background)))))) (CIT (-LRB- -LRB-) (NNP J.) (NNP Hoover) (HYPH -) (NNP Plow) (, ,) (NNP A.) (NNP Shchurin) (, ,) (CC and) (NNP E.) (NNP Hart) (, ,) (JJ unpublished) (NNS results) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ (NP (DT The) (NNS results)) (PP (IN of) (NP (DT this) (NN study)))) (VP (VBP suggest) (SBAR (SBAR (IN that) (CONJP (RB not) (RB only)) (SINV (VBZ is) (NP-SBJ-1 (NN bleeding) (NN time)) (ADVP (RB genetically)) (VP (VBN determined) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NN background)))))) (, ,) (CONJP (CC but) (RB also)) (SBAR (IN that) (S (NP-SBJ-2 (NML (NN tail) (NN rebleeding)) (NN time)) (VP (VBZ is) (ADVP-MNR (RB genetically)) (VP (VBN determined) (NP-2 (-NONE- *)))))))) (. .)) )
( (S (SBAR-TMP (IN While) (S (NP-SBJ (NN blood) (NN pressure)) (VP (MD could) (ADVP (RB conceivably)) (VP (VB be) (ADJP-PRD (JJR higher)) (PP-LOC (IN in) (NP (NP (NNS mice)) (PP (IN with) (NP (VBN elevated) (NML (NN tail) (NN bleeding)) (NN time))))))))) (, ,) (NP-SBJ (JJ several) (NNS studies)) (VP (VBP suggest) (SBAR (IN that) (S (NP-SBJ (DT this)) (VP (VBZ is) (RB not) (NP-PRD (DT the) (NN case)))))) (. .)) )
( (S (NP-SBJ (NP (NNS Studies)) (PP (IN of) (NP (NML (NN A) (HYPH /) (NN J) (PRN (-LRB- [) (NP (NP (CD 33)) (PP (SYM -) (NP (CD 36)))) (-RRB- ]))) (NNS mice)))) (VP (VBP have) (VP (VBN reported) (NP (NP (CC either) (NP (VBN decreased) (NN blood) (NN pressure)) (CC or) (NP (DT no) (NN difference))) (PP (VBN compared) (PP (IN to) (NP (DT the) (NN B6) (NNS mice))))))) (. .)) )
( (S (S (S (NP-SBJ-1 (NN Blood) (NN pressure)) (VP (VBD was) (VP (VBN measured) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (DT the) (NML (NN Plg) (SYM -) (HYPH /) (SYM -)) (NNS mice))) (CIT (-LRB- -LRB-) (NNP D.) (NNP Hellard) (, ,) (NNP J.) (NNP Hoover) (HYPH -) (NNP Plow) (, ,) (CC and) (NNP E.) (NNP Plow) (, ,) (JJ unpublished) (NNS results) (-RRB- -RRB-))))) (, ,) (CC and) (S (NP-SBJ (DT these) (NNS mice)) (VP (VBP have) (NP (VBN reduced) (NN blood) (NN pressure)) (SBAR-TMP (WHADVP-3 (WRB when)) (S (NP-SBJ-2 (-NONE- *PRO*)) (VP (VBN compared) (NP-2 (-NONE- *)) (PP (IN to) (NP (JJ WT) (NNS littermates))) (ADVP-TMP-3 (-NONE- *T*))))))) (, ,) (CC and) (S (NP-SBJ (NML (NML (NN uPA) (SYM -) (HYPH /) (SYM -) (PRN (-LRB- [) (NP (CD 37)) (-RRB- ]))) (CC and) (NML (NN Lepob) (PRN (-LRB- [) (NP (CD 38) (, ,) (CD 39)) (-RRB- ])))) (NNS mice)) (ADVP (RB also)) (VP (VBP have) (NP (VBN reduced) (NN blood) (NN pressure))))) (, ,) (CC but) (S (NP-SBJ (EX there)) (VP (VBZ is) (NP-PRD (NP (DT no) (NN correspondence)) (PP (IN between) (NP (NP (NN blood) (NN pressure)) (CC and) (NP (NN tail) (NML (NN bleeding) (CC or) (NN rebleeding)) (NNS times))))))) (. .)) )
( (S (NP-SBJ (NP (JJ Morphometric) (NN analysis)) (PP (IN of) (NP (DT the) (NN tail)))) (VP (VBD indicated) (NP (NP (DT a) (NN difference)) (PP (IN in) (NP (NP (DT the) (NN collagen) (NN content)) (PP (IN of) (NP (DT the) (NN tail))))) (PP-LOC (IN in) (NP (DT the) (NML (NN A) (HYPH /) (NN J)) (NNS mice))))) (. .)) )
( (S (NP-SBJ (NP (NNS Differences)) (PP (IN in) (NP (NP (DT the) (NML (NN structure) (CONJP (CC and) (HYPH /) (CC or)) (NN metabolism))) (PP (IN of) (NP (NP (NN collagen)) (CC or) (NP (JJ extracellular) (NN matrix) (NN proteins))))))) (VP (MD may) (VP (VP (VB contribute) (PP (IN to) (NP (DT the) (NML (NML (VBN increased) (NN rebleeding)) (CC and) (NML (VBD reduced) (NN occlusion))) (NN time))) (PP-LOC (IN in) (NP (DT the) (NML (NN A) (HYPH /) (NN J)) (NNS mice)))) (CC and) (VP (VB warrant) (NP (JJ further) (NN investigation))))) (. .)) )
( (S (NP-SBJ (NP (DT The) (NNS genes)) (PP (IN for) (NP (NP (NN Plg)) (, ,) (NP (NN PAI) (HYPH -) (CD 1)) (, ,) (CC and) (NP (NN α2) (HYPH -) (NN antiplasmin))))) (VP (VP (VBP reside) (PP (IN on) (NP (NP (DT the) (CD three) (NNS chromosomes)) (VP (VBN identified) (NP (-NONE- *)) (PP (IN for) (NP (NP (NN QTL)) (PP (IN for) (NP (NN rebleeding) (NN time))))))))) (CC and) (VP (VP (MD may) (VP-1 (-NONE- *RNR*))) (CC or) (VP (MD may) (RB not) (VP-1 (-NONE- *RNR*))) (VP-1 (VB be) (ADJP-PRD (JJ coincidental) (PP (IN to) (NP (NP (DT the) (VBN observed) (NNS phenotypes)) (VP (VBN found) (NP (-NONE- *)) (PP-LOC (IN in) (NP (DT the) (NML (NN A) (HYPH /) (NN J)) (NML (NNS mice) (CC and) (NNS CSS))))))))))) (. .)) )
( (S (NP-SBJ (NP (PRP It)) (SBAR-1 (-NONE- *EXP*))) (VP (VBZ is) (RB not) (ADJP-PRD (JJ likely)) (SBAR-1 (IN that) (S (NP-SBJ (NP (ADVP (RB merely)) (DT the) (NN concentration)) (PP (IN of) (NP (DT these) (NNS components)))) (VP (VBZ explains) (NP (NP (DT the) (NML (NML (VBN increased) (NN rebleeding) (NN time)) (CC and) (NML (VBN reduced) (NML (JJ arterial) (NN occlusion)) (NN time)))) (PP-LOC (IN in) (NP (DT the) (NML (NN A) (HYPH /) (NN J)) (NNS mice)))))))) (. .)) )
( (S (SBAR-TMP (WHADVP-2 (WRB When)) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN compared) (NP-1 (-NONE- *)) (PP (IN to) (NP (DT the) (NN B6) (NNS mice))) (ADVP-TMP-2 (-NONE- *T*))))) (, ,) (NP-SBJ (NP (NP (DT the) (NML (NN A) (HYPH /) (NN J)) (NNS mice)) (CC and) (NP (DT the) (CD three) (NNS strains))) (PP (IN with) (NP (JJ elevated) (NN rebleeding) (NN time)))) (VP (VBD had) (NP (JJ variable) (NML (NML (NN Plg)) (, ,) (NML (NN PAI) (HYPH -) (CD 1)) (, ,) (CC and) (NML (NN α2) (HYPH -) (NN antiplasmin))))) (. .)) )
( (S (NP-SBJ-1 (NP (CD Two) (JJ allelic) (NNS forms)) (PP (IN of) (NP (DT the) (NN mouse) (NN Plg) (NN gene)))) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (NP-1 (-NONE- *)) (PP (IN for) (NP (NML (NML (NN B6)) (CC and) (NML (NN A) (HYPH /) (NN J))) (NNS mice))) (PRN (-LRB- [) (NP (CD 40)) (-RRB- ]))))) (. .)) )
( (S (NP-SBJ-1 (NN Plg) (NN concentration)) (VP (VBD was) (VP (VBN increased) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NML (NN A) (HYPH /) (NN J)) (NNS mice))) (PP (VBN compared) (PP (IN to) (NP (NN B6) (NNS mice)))))) (. .)) )
( (S (SBAR-ADV (IN Although) (S (NP-SBJ (PRP we)) (VP (VBD did) (RB not) (VP (VB detect) (NP (NP (NNS differences)) (PP (IN in) (NP (NN Plg) (NN structure)))))))) (, ,) (NP-SBJ (DT this)) (VP (MD would) (RB not) (VP (VB exclude) (NP (JJ possible) (JJ functional) (NNS differences)))) (. .)) )
( (S (NP-SBJ-3 (NP (NP (NP (DT A) (JJ congenic) (NN strain)) (-LRB- -LRB-) (ADJP (JJ specific) (PP (IN for) (NP (NP (DT a) (JJ homosomic) (NN region)) (PP (IN from) (NP (NP (NN A) (HYPH /) (NN J)) (CC and) (NP (DT the) (VBG remaining) (NN Chr)))) (PRN (CC and) (S (NP-SBJ (NN background)) (VP (VBZ is) (PP-PRD (IN from) (NP (NN B6) (NNS mice))))) (-RRB- -RRB-)))))) (PP (IN of) (NP (NML (NN A) (HYPH /) (NN J)) (NN chromosome) (CD 17)))) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBZ includes) (NP (DT the) (NN Plg) (NN gene)))))) (VP (VBD was) (VP (VBN tested) (NP-3 (-NONE- *)) (PP (IN in) (NP (DT the) (NN bleeding) (NN assay))))) (. .)) )
( (S (NP-SBJ (NP (NNS Values)) (PP (IN for) (NP (NN bleeding) (CC and) (NN rebleeding))) (PP-LOC (IN in) (NP (DT this) (JJ congenic) (NN strain)))) (VP (VBD were) (ADJP-PRD (JJ similar) (PP (IN to) (NP (NP (NNS values)) (PP (IN from) (NP (NN B6) (NNS mice)))))) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG indicating) (SBAR (IN that) (S (NP-SBJ (DT the) (NN QTL)) (VP (VBZ is) (RB not) (NP-PRD (NN Plg)))))))) (. .)) )
( (S (NP-SBJ (EX There)) (VP (VBP are) (NP-PRD (NP (NNS genes)) (PP (IN for) (NP (NP (JJ other) (NML (NML (NNS proteases)) (CC and) (NML (NN matrix) (NN proteins)))) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBP reside) (PP (IN on) (NP (NN chromosome) (CD 17))))))))) (PP (IN in) (NP (NP (NN addition)) (PP (IN to) (NP (JJ unknown) (NNS genes)))))) (. .)) )
( (S (S (NP-SBJ (NP (NN DNA) (NML (NN base) (NN pair) (NN sequence)) (NNS data)) (PP (IN for) (NP (NP (DT the) (NML (NN PAI) (HYPH -) (CD 1)) (NN gene)) (CC or) (NP (DT the) (NML (NN α2) (HYPH -) (NN antiplasmin)) (NN gene)))) (PP-LOC (IN in) (NP (NML (NML (NN B6)) (CC and) (NML (NN A) (HYPH /) (NN J))) (NNS mice)))) (VP (VBP have) (VP (VBN reported) (NP (DT no) (NNS differences)) (PRN (-LRB- [) (NP (CD 51)) (-RRB- ]))))) (, ,) (CC but) (S (NP-SBJ (NP (JJ regulatory) (NNS genes)) (ADVP-LOC (RB upstream) (PP (IN of) (NP (DT the) (VBG coding) (NN region))))) (VP (MD may) (VP (VB be) (ADJP-PRD (JJ important))))) (. .)) )
( (S (NP-SBJ (PRP$ Our) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (NP-SBJ (ADJP (JJ novel) (CC or) (JJ unknown)) (NNS genes)) (VP (MD may) (VP (VB interact) (PP (IN with) (NP (DT the) (NML (NN Plg) (NN system)) (NNS components))) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB modify) (NP (PRP$ their) (NN function)))))))))) (. .)) )
( (S (PP (IN In) (NP (NN summary))) (, ,) (NP-SBJ (DT this) (NN study)) (VP (VBZ reports) (NP (NP (JJ marked) (NNS differences)) (PP-LOC (IN in) (NP (NP (NP (CD two) (JJ inbred) (NNS strains)) (PP (IN of) (NP (NNS mice)))) (, ,) (NP (NP (NN B6)) (CC and) (NP (NN A) (HYPH /) (NN J))))) (, ,) (PP (IN in) (NP (NP (NP (NML (JJ arterial) (NN thrombosis)) (NN formation)) (PP (IN in) (NP (DT a) (NN FeCl3) (NML (JJ vascular) (NN injury)) (NN model)))) (, ,) (NP (NP (NN rebleeding) (NN time)) (PP (IN in) (NP (DT a) (NML (NN tail) (NN bleeding)) (NN assay)))) (, ,) (NP (NN plasminogen) (NN function)) (, ,) (CC and) (NP (NML (NN tissue) (CC and) (NN vessel)) (NN collagen) (NN deposition)))))) (. .)) )
( (S (NP-SBJ-1 (NP (NP (CD Three) (NNS chromosomes)) (PP (IN from) (NP (NML (NN A) (HYPH /) (NN J)) (NNS mice)))) (SBAR-3 (-NONE- *ICH*))) (VP (VBD were) (VP (VBN identified) (NP-1 (-NONE- *)) (SBAR-3 (WHNP-2 (WDT that)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBD had) (NP (NP (NN QTL)) (PP (IN for) (NP (NN rebleeding) (NN time))))))))) (. .)) )
( (S (NP-SBJ (DT The) (NNS genes)) (VP (MD may) (VP (VP (VB interact) (PP (IN with) (NP (NP (NNS components)) (PP (IN in) (NP (DT the) (NN Plg) (NN network)))))) (CC and) (VP (VB modulate) (NP (NML (JJ arterial) (NN occlusion)) (NN time))))) (. .)) )
( (HEADING (NP (NN Conclusion))) )
( (S (NP-SBJ-1 (NP (DT The) (JJ marked) (JJ independent) (NNS differences)) (VP (VBN demonstrated) (NP (-NONE- *)) (PP-LOC (IN in) (NP (DT the) (NML (NML (NN B6)) (CC and) (NML (NN A) (HYPH /) (NN J))) (NNS mice))))) (VP (MD can) (VP (VB be) (VP (VBN exploited) (NP-1 (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB identify) (NP (NP (JJ genetic) (NNS determinants)) (PP (IN of) (NP (NN thrombosis) (CC and) (NN haemostasis)))))))))) (. .)) )
( (S (NP-SBJ (NP (PRP$ Our) (NNS results)) (PP (IN of) (NP (DT the) (NN CSS) (NN screening)))) (VP (VBP suggest) (SBAR (IN that) (S (NP-SBJ-1 (ADJP (JJ novel) (CC or) (JJ unknown)) (NNS genes)) (VP (MD can) (VP (VB be) (VP (VBN used) (NP-1 (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB identify) (NP (NP (DT the) (NNS genes)) (ADJP (JJ responsible) (PP (IN for) (NP (NP (NP (DT the) (NNS traits)) (ADJP (VBN related) (PP (IN to) (NP (JJ arterial) (NN thrombosis))))) (, ,) (NP (NP (NN tail) (NML (NN bleeding) (HYPH /) (NN rebleeding))) (CC and) (NP (NN vessel) (JJ extracellular) (NN matrix)))))))))))))))) (. .)) )
( (S (NP-SBJ (NP (NP (NN Identification)) (PP (IN of) (NP (NP (NNS differences)) (PP-LOC (IN in) (NP (DT the) (NN parent) (NNS strains))) (, ,) (PP (JJ such) (IN as) (NP (NP (DT those)) (VP (VBN described) (NP (-NONE- *)) (PP (IN in) (NP (DT this) (NN study))))))))) (, ,) (CC and) (NP (NP (NN screening)) (PP (IN of) (NP (DT the) (NN CSS))))) (VP (VBZ is) (NP-PRD (NP (DT a) (JJ first) (HYPH -) (NN step)) (PP (IN in) (NP (NP (DT the) (NN discovery)) (PP (IN of) (NP (NP (JJ new) (JJ genetic) (NNS determinants)) (PP (IN of) (NP (JJ thrombotic) (NN risk))))))))) (. .)) )
( (HEADING (NP (NNS Abbreviations))) )
( (S-FRM (NP-SBJ (NN B6)) (VP (SYM =) (NP (NN C57BL) (HYPH /) (NN 6J)))) )
( (S-FRM (NP-SBJ (NNS CSS)) (VP (SYM =) (NP (NN chromosome) (NN substitution) (NNS strains)))) )
( (S-FRM (NP-SBJ (NN CSS) (HYPH -) (NN #)) (VP (SYM =) (NP (NML (NN B6) (HYPH -) (NN Chr)) (NN #) (NN A) (HYPH /) (NN J)))) )
( (S-FRM (NP-SBJ (NN CSS) (HYPH -) (NN #) (NN F1)) (VP (SYM =) (NP (-LRB- -LRB-) (NML (NN B6) (SYM ×) (NN CSS)) (HYPH -) (NN #) (-RRB- -RRB-) (NN F1)))) )
( (S-FRM (NP-SBJ (NN WT)) (VP (SYM =) (NP (JJ wild) (HYPH -) (NN type)))) )
( (S-FRM (NP-SBJ (SYM -) (HYPH /) (SYM -)) (VP (SYM =) (ADJP-PRD (JJ deficient)))) )
( (S-FRM (NP-SBJ (NN Plg)) (VP (SYM =) (NP (NN plasminogen)))) )
( (S-FRM (NP-SBJ (NN PAI) (HYPH -) (CD 1)) (VP (SYM =) (NP (NML (NN plasminogen) (NN activator)) (NN inhibitor) (HYPH -) (CD 1)))) )
( (S-FRM (NP-SBJ (NN tPA)) (VP (SYM =) (NP (NML (NN tissue) (NN plasminogen)) (NN activator)))) )
( (S-FRM (NP-SBJ (NN uPA)) (VP (SYM =) (NP (NML (NN urokinase) (NN plasminogen)) (NN activator)))) )
( (S-FRM (NP-SBJ (NN SEM)) (VP (SYM =) (NP (NP (JJ standard) (NN error)) (PP (IN of) (NP (DT the) (NN mean)))))) )
( (S-FRM (NP-SBJ (NN QTL)) (VP (SYM =) (NP (NML (JJ quantitative) (NN trait)) (NN locus)))) )
( (HEADING (NP (VBG Competing) (NNS interests))) )
( (S (NP-SBJ (DT The) (NN author) (-LRB- -LRB-) (AFX s) (-RRB- -RRB-)) (VP (VBP declare) (SBAR (IN that) (S (NP-SBJ (PRP they)) (VP (VBP have) (NP (DT no) (VBG competing) (NNS interests)))))) (. .)) )
( (HEADING (NP (NP (NNS Authors) (POS ')) (NNS contributions))) )
( (S (NP-SBJ (NNP JHP)) (VP (VP (VBD conceived) (CC and) (VBD designed) (NP (DT the) (NN study))) (, ,) (VP (VBD coordinated) (NP (DT the) (NNS experiments))) (CC and) (VP (VBD drafted) (NP (DT the) (NN manuscript)))) (. .)) )
( (S (NP-SBJ (NNP AS)) (VP (VP (VBD developed) (CC and) (VBD performed) (NP (DT the) (NML (NN tail) (NN bleeding)) (NN assay))) (CC and) (VP (VBD participated) (PP (IN in) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG drafting) (NP (DT the) (NN manuscript))))))) (. .)) )
( (S (NP-SBJ (NNP EH)) (VP (VP (VBD carried) (PRT (RP out)) (NP (NP (DT the) (NML (JJ vascular) (NN injury)) (NN model)) (CC and) (NP (NNS analyses)) (CC and) (NP (DT the) (NML (NN tail) (NN bleeding)) (NN assay)))) (, ,) (VP (VBD participated) (PP (IN in) (NP (NP (DT the) (NML (NN tail) (NN collagen)) (NNS analyses)) (, ,) (CC and) (NP (NP (NN coordination)) (PP (IN of) (NP (DT the) (NN mouse) (NN breeding)))))))) (. .)) )
( (S (NP-SBJ (NNP JS)) (VP (VBD participated) (PP (IN in) (NP (NP (NP (DT the) (NN analysis)) (PP (IN of) (NP (DT the) (NML (NML (JJ vascular) (NN injury)) (NN model)) (NNS results)))) (CC and) (NP (NN collagen) (NNS analyses))))) (. .)) )
( (S (S (NP-SBJ (NNP JHN) (CC and) (NNP AHE)) (VP (VBD provided) (NP (DT the) (NN CSS) (NN breeding) (NNS pairs)))) (, ,) (S (NP-SBJ (NNP JHN)) (VP (VBD participated) (PP (IN in) (NP (NP (NNS discussions)) (PP (IN of) (NP (DT the) (NNS results))))))) (, ,) (CC and) (S (NP-SBJ (NNP JBS) (CC and) (NNP JHN)) (VP (VBD developed) (NP (DT the) (NN CSS)))) (. .)) )
( (S (NP-SBJ (PDT All) (DT the) (NNS authors)) (VP (VBP have) (VP (VBN read) (CC and) (VBN approved) (NP (DT the) (JJ final) (NN manuscript)))) (. .)) )
( (HEADING (NP (JJ Pre-publication) (NN history))) )
( (S (NP-SBJ-1 (NP (DT The) (JJ pre-publication) (NN history)) (PP (IN for) (NP (DT this) (NN paper)))) (VP (MD can) (VP (VB be) (VP (VBN accessed) (NP-1 (-NONE- *)) (ADVP (RB here))))) (: :)) )
( (HEADING (NP (NNS Acknowledgements))) )
( (S (NP-SBJ (DT The) (NNS authors)) (VP (VP (VBD thank) (NP=2 (NP (NNP Dr.) (NNP A.) (NNP Vasanji)) (, ,) (NP (NNP Shiyang) (NNP Wang)) (, ,) (CC and) (NP (NNP Jenna) (NNP Saraniti))) (PP-PRP=1 (IN for) (NP (NP (NN assistance)) (PP (IN with) (NP (NN image) (NNS analyses)))))) (, ,) (VP (NP=2 (NNP David) (NNP Hellard)) (PP-PRP=1 (IN for) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG performing) (NP (DT the) (NML (NN blood) (NN pressure)) (NNS measurements)))))) (, ,) (VP (NP=2 (NNP Dr.) (NNP Y.Shchurina)) (PP-PRP=1 (IN for) (NP (DT the) (NN plasminogen) (NNS analyses)))) (, ,) (VP (NP=2 (NP (NNPS Drs.) (NNP Lindsey) (NNP Burrage)) (CC and) (NP (NNP Jonathan) (NNP Smith))) (PP-PRP=1 (IN for) (NP (JJ helpful) (NNS discussions)))) (, ,) (CC and) (VP (NP=2 (NNP Robin) (NNP Lewis)) (PP-PRP=1 (IN for) (NP (NP (NN assistance)) (PP (IN with) (NP (NN manuscript) (NN preparation))))))) (. .)) )
( (S (NP-SBJ-1 (DT This) (NN study)) (VP (VBD was) (VP (VBN supported) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NP (NP (NNS grants)) (PP (IN from) (NP (NNP NIH)))) (, ,) (NP (NP (NN HL17964) (, ,) (NN HL65204) (, ,) (NN HL078701) (PRN (-LRB- -LRB-) (NP (NNP JHP)) (-RRB- -RRB-))) (, ,) (NP (NN T32) (NN HL07914) (PRN (-LRB- -LRB-) (NP (NNP AS)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NN RR12305) (PRN (-LRB- -LRB-) (NP (NNP JHN)) (-RRB- -RRB-)))))))) (. .)) )
